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Thesis Abstract: Post-Stroke Apathy: Screening and Functional Impact 
 
Pernille Spillum Myhre 
Year of submission: 2020 
 
Background: Apathy, a disorder of motivation observed in up to 40% of stroke survivors, is 
likely to have a negative impact on stroke rehabilitation. It is often theorised to be a 
multidimensional construct yet frequently assessed using unidimensional measures. The 
Dimensional Apathy Scale (DAS, Radakovic & Abrahams, 2014) is a multidimensional 
assessment, with Executive, Emotional and Initiation Apathy subscales. The aims of this 
thesis were to examine the relationship between apathy and functional activity after stroke and 
assess the suitability of the DAS as a screen for post-stroke apathy (PSAp).  
Method: A systematic review identified 8 papers investigating the associations between 
PSAp and functional activity. An online survey of 53 stroke, and 71 non-stroke participants 
investigated the psychometric properties and validity of the DAS in relation to a frequently 
used, unidimensional apathy measure and measures of depression and anxiety. 
Results: The systematic review found that PSAp is associated with negative outcomes, 
including negatively affecting family life and later social reintegration and autonomy. The 
review highlights a negative relationship between PSAp and functional activity, although 
there were concerns regarding the quality of studies and the lack of multidimensional apathy 
assessment being utilised. The survey found that the DAS has good internal consistency, good 
convergent and divergent validity in stroke. Stroke survivors scored significantly higher on 
total apathy and all subscales than did non-stroke participants. Initiation and Executive 
Apathy were particularly prevalent, similar to previous DAS validation studies in 
neurogenerative diseases. Stroke survivors also had significantly higher levels of depression, 
but not anxiety, compared with non-stroke participants.  
Conclusion: PSAp is common but under-researched. This thesis contributes to PSAp 
research, finding that PSAp is associated with functional disability and validating the DAS for 
use in stroke rehabilitation and research. Limitations and suggestions for future research are 
discussed. 
 
 
 
 
 
 
 
 
POST-STROKE APATHY    8 
 
Summary of Portfolio 
Chapter 1: The first chapter provides a general introduction to the thesis, outlining the 
nature and importance of stroke and its consequences, including emotional and cognitive 
sequelae and impact on functional activities. It also introduces post-stroke apathy and 
theoretical models of apathy and PSAp.  
Chapter 2: The second chapter presents a systematic review examining the 
association between apathy and functional activity after stroke. Eight articles, involving 1517 
patients, were selected for review. Internal validity was rated ‘good’ in four studies, 
uncertainties and risk of bias affecting external validity were identified in all studies. PSAp 
was found to be prevalent and negatively associated with rehabilitation outcomes. Most 
studies used unidimensional measures of apathy, thereby failing to characterise apathy 
according to apathy subtype. 
Chapter 3: The third chapter provides a bridge between the systematic review of the 
impact of PSAp on functional activities and an article on the first validation of a 
multidimensional assessment of apathy (the Dimensional Apathy Scale, DAS) in stroke. It 
provides an overview of theoretical models and research evidence on the dimensionality of 
apathy. It also covers methodological considerations regarding validation studies of clinical 
screening tools.   
Chapter 4: The fourth chapter presents a validation study of the DAS in stroke. This 
scale has been validated for people with a range of neurodegenerative diseases, but not yet for 
stroke. The chapter discusses the scale and apathy as a multidimensional concept. This study 
is based on data from an online questionnaire, comparing stroke survivors and controls 
(people who had not experienced a stroke). The DAS showed high internal consistency and 
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good convergent and divergent validity with the Apathy Evaluation Scale (AES), Patient 
Health Questionnaire (PHQ-9) and Generalised Anxiety Disorder scale (GAD-7).  
Chapter 5: The fifth chapter includes additional methods regarding assumptions for 
ANOVA and non-parametric data.  
Chapter 6: The sixth and final chapter provides an extended discussion and critical 
appraisal to integrate and summarise the findings from this thesis.  
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General Introduction 
Introducing stroke, apathy, post-stroke apathy and recovery 
Stroke 
The word ‘stroke’ relates to the Greek word ‘apoplexia,’ which translates to ‘being 
struck with a deadly blow’ (Coupland, Thapar, Qureshi, Jenkins, & Davies, 2017). A stroke is 
a life-threatening medical emergency, which is the leading cause of disability, and the fourth 
most common cause of death in the UK (Stroke Association, 2017). There are over 100.000 
new cases and 38.000 stroke related deaths each year, and an astonishing 1.2 million stroke 
survivors currently living in the UK (National Institue ofor Health and Care Excellence, 
2019a). Stroke-related disability is costly on human, family and societal levels (Carod-Artal 
& Egido, 2009). In the UK, the total societal cost of stroke is estimated to be £8.9 billion a 
year, and the productivity loss due to death and disability is estimated to be £1.5 billion a year 
(Saka, Mcguire, & Wolfe, 2009). 
Stroke is a clinical syndrome, caused by an intracranial vascular event. The World 
Health Organisation define stroke as “rapidly developing clinical signs of focal (or global) 
disturbance of cerebral function, with symptoms lasting 24 hours or longer or leading to 
death, with no apparent cause other than of vascular origin” (Sacco et al., 2013, p. 2065). 
There are two main types of stroke: Ischemic strokes are the most common (about 85% of all 
strokes), caused by a blocked blood vessel: Haemorrhagic strokes are caused by bleeding in 
the brain (Royal College of Physicians, 2016; Stroke Association, 2017). A Transient 
Ischemic Attack, or TIA, is a temporary blockage of the blood flow to the brain, lasting less 
than 24 hours, and is often referred to as a “mini-stroke” (Stroke Association, 2017). This is 
considered a warning sign but is not categorised as a major stroke.  
The effects of a stroke can be extremely varied, depending on localisation in the brain, 
as well as the extent and severity of the damage (Stroke Association, 2017). The International 
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Classification of Functioning, Disability and Health (ICF) model, presented in Figure 1, 
shows how people might experience disabilities from any types of illness impacting sensation, 
movement, cognition, communication and emotion, and how these are affecting functional 
activities, which are in turn affecting social participation, mood and psychosocial adjustment 
(World Health Organisation, 2013).  
Figure 1 
The ICF Model: Interaction between ICF components, retrieved from World Health 
Organisation, (2013) 
 
Body functions or structures can include various cognitive impairments, aphasia, 
emotional changes, incontinence, visual impairments, limb weakness, difficulties swallowing, 
motor impairments and balance problems, fatigue and pain (Stroke Association, 2017); they 
are notable factors which influence one’s ability to participate in activities. Activities and 
participation refer to an individual’s capacity and performance in any chosen activity. 
Environmental structures include family, friends, work, health care and rehabilitation 
services. Personal factors include age, gender, general health, and coping strategies (World 
Health Organisation, 2013). These contextual factors can be considered either to be 
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supportive, or work as barriers by inhibiting the ability to function and participate, they are 
related to one’s functional abilities post stroke (World Health Organisation, 2013).  
For health professional and teams working with the patient, it is helpful to provide a 
context for which one can understand the person, as well as the cognitive, emotional physical 
and communication consequences after brain injury such as stroke, (Wilson, Gracey, Evans, 
& Bateman, 2009). Figure 2 presents a model used at the Oliver Zangwill Centre, in 
Cambridge UK, encompassing biopsychosocial factors to help formulate the nature of the 
injury and its effect on the person, (Wilson et al., 2009). This model can be used to create an 
individual formulation for the person, to aid understanding and to identify strengths, 
weaknesses and needs, informing recovery goals, by considering internal as well as external 
factors.  
Figure 2 
A biopsychosocial model of the consequences of brain injury from the Oliver Zangwill Centre, 
retrieved from (Wilson et al., 2009) 
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Acute Treatment and Stroke Rehabilitation 
In acute stroke care, emphasis is on medical stabilisation, assessment and 
rehabilitation, it is important for the latter to commence in acute care (Lynch, Mackintosh, 
Luker, & Hillier, 2019). In terms of treatment, the National Institute for Health and Care 
Excellence (NICE) recommends a thorough assessment and specialist care, with treatment 
from a multidisciplinary team approach supporting rehabilitation (NICE, 2019b). 
Rehabilitation can take place either in specialist multidisciplinary inpatient or outpatient 
services, dependent on the client’s needs (Teasell et al., 2009). The main focus in 
rehabilitation is on the adaptation, restitution and neuroplasticity (Belagaje, 2017). 
Rehabilitation improves the person’s immediate and long-term functioning (Lynch et al., 
2019; Teasell et al., 2009).  
Much of a person’s recovery often take place in the first few months following a 
stroke (Powers et al., 2018; Ramsey et al., 2017). Some stroke survivors will fully recover 
after stroke, whilst others will have to live with disabilities for the remainder of their 
respective lives (Boccuni et al., 2018). The level of paralysis and recovery of function in the 
first few days following a stroke predicts later treatment outcomes of motor-function recovery 
(Hendricks, Limbeek, & Geurts, 2002; Ramsey et al., 2017). Rehabilitation after stroke 
requires sustained efforts from the stroke survivor, a multidisciplinary team, as well as 
support from the stroke survivor’s social network  (Winstein et al., 2016).  
 NICE highlights the importance of smart-goals to guide the recovery process, these 
should be formed together with the stroke survivor, allowing consideration for a wide scope 
of factors, including severity, symptoms, available support, function before stroke etc. (NICE, 
2019). Recovering from a stroke can be a lengthy process, requiring much motivation from 
the individual and their support system. A stroke can be, as mentioned above, a major event in 
one’s life, requiring significant change and adaptation.  
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Strokes can have a high emotional impact, and many stroke survivors experience 
emotional difficulties following a stroke (Douven et al., 2018; Matsuzaki et al., 2015; Sagen 
et al., 2010). Rapid detection of factors delaying stroke rehabilitation is important to allow 
patients to fully utilise the offered rehabilitation programs (Lynch et al., 2019), and factors 
such as post-stroke depression (PSD) deserve greater focus in stroke given its negative 
influence on rehabilitation  (Balkaya & Cho, 2019).  
Emotional and motivational consequences of stroke 
Depression is prevalent: it is observed in one third of stroke-survivors (Robinson & 
Jorge, 2016). PSD is associated with higher mortality rates and poorer rehabilitation outcomes 
(Towfighi et al., 2017; Williams, Ghose, & Swindle 2004). Physical disabilities, cognitive 
impairments, lack of family and social support, and premorbid depression are considered risk-
factors for developing PSD (Robinson & Jorge, 2016; Towfighi et al., 2017). A 
comprehensive systematic review found that cognitive impairments, physical disability and 
stroke severity were predominant predictors for developing post-stroke depression (Hackett, 
Köhler, O’Brien, & Mead, 2014).  
Approximately 50% of stroke survivors exhibit anxiety and depressive symptoms 
which continue several years after stroke (Bergersen, Frøslie, Stibrant Sunnerhagen, & 
Schanke, 2010). Post-stroke depression can be understood from a biopsychosocial 
perspective, where neurological changes following the stroke, psychological and 
environmental consequences and factors might emotionally impact the stroke-survivor at 
varying degrees, given their personal and unique context (Hackett, Hons, & Anderson, 2005).  
There can be several consequences of a significant aversive life event, such as stroke, 
which might impact upon function and motivation. The emotional impact can be linked with 
the mourning of loss (of abilities) and coping with acceptance of disability, particularly when 
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individuals struggle or refuse to accept their new reality (Hama, Yamashita, Yamawaki, & 
Kurisu, 2011). It was argued that loss of identity and changes to the sense-of-self are common 
after stroke: subsequently, this can have a negative impact on one’s self-esteem (Lapadatu & 
Morris, 2019). A study found that greater identity discrepancies between the actual and ideal 
self was associated with anxiety, depression and lower quality of life (Lapadatu & Morris, 
2019).  
Post-stroke anxiety is another common neuropsychiatric disorder in stroke survivors, 
and it is a frequently comorbid with PSD (Barker-Collo, 2007; Lincoln et al., 2013; Sagen et 
al., 2010). It is estimated that a quarter of stroke survivors will experience post-stroke anxiety 
(Hackett et al., 2014). Anxiety can be very disabling to the individual: fears can either be 
general or more specific, often related with incidents and situations such as fear of falling, 
stroke recurrence, fear of headaches, fear of physical exertion (such as exercise and having 
sex), and fear of being alone (Chun, Whiteley, Dennis, Mead, & Carson, 2018). These fears 
can impact one’s activity levels and quality of life (Morris, Van Wijck, Joice, & Donaghy, 
2013).   
 A stroke can be a very traumatic and life-threatening experience, some stroke-
survivors develop Post Traumatic Stress Disorder (PTSD), (Merriman, Norman, & Barton, 
2007). The prevalence varies in the literature, ranging from anything between 3-20% of 
stroke-survivors in the first year (Edmondson et al., 2013).  
From a social perspective, a relative experiencing stroke can also impact on an entire 
family system and social environment: a sudden and unexpected disability in the family will 
often lead to changes in roles (e.g. changing from being a spouse to spouse and a carer), 
(Dam, Tonin, Casson, Ermani, & Pizzolato, 1993).  
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Emotionalism and emotional adjustment after stroke 
 Emotional disturbances are common after stroke and can affect social reintegration. 
These disturbances encompass a wide array of emotions, including anger, anxiety/fear, 
indifference, lack of emotional understanding and reduced emotional control (Ferro & Santos, 
2019). Outbursts of involuntary crying and laughing (emotionalism) is a common 
consequence of stroke (McAleese, Guzman, O’Rourke, & Gillespie, 2019). The attribution of 
symptom origin is an important predictor for the stroke survivor’s wellbeing when 
experiencing involuntary symptoms (McAleese et al., 2019). 
There are great individual differences in terms of coping after stroke (Taylor et al., 
2011). Difficulties with emotional adjustment is common amongst stroke survivors, and 
emotional adjustment is not a linear process (Smith et al., 2019; Taylor et al., 2011). Stroke 
survivors are frequently influenced by positive or negative triggering events, negative events 
might include set-backs (Smith et al., 2019). Taylor and colleges (2011) provided a Social 
Cognitive Transaction Model adapted for stroke, see Figure 3. This model shows the complex 
range of adjustment experiences that that the stroke survivor might alternate between (Taylor 
et al., 2011). 
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Figure 3 
Social Cognitive Transition Model with a clinical example, retrieved from (Taylor et al., 
2011).  
 
Apathy 
The word apathy stems from the Greek words: a (without) patos (passion), (Stuss, van 
Reekum, & Murphy, 2000), and can be defined as the lack of motivation for goal directed 
behaviours (Marin, Biedrzycki, & Firinciogullari, 1991). The term motivation has been 
defined as: 
A driving force or forces responsible for the initiation, persistence, direction, and 
vigour of goal-directed behaviour. It includes the biological drives such as hunger, 
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thirst, sex, and self-preservation, and also social forms of motivation such as need for 
achievement and need for affiliation. (Colman, 2005, p. 224).  
The strength of motivation can be considered as a continuum, with high motivation at 
one end and diminished motivation at the the other (Marin and Wilkosz, 2005). Apathy is 
considered to be a state of diminished motivation and falls towards the lower end of a 
motivation continuum, as do other disorders of motivation such as akinetic mutism and abulia 
(Marin, 1997; Marin et al., 2005). Apathy can have various causes and can be understood 
from situational and psychiatric approaches, such as depression, psychosis and schizophrenia 
(Konstantakopoulos et al., 2011), or neurological domains.  
Apathy is highly prevalent across neurological disorders (Chase, 2011), it can be 
found in 43% of patients with mixed dementia (Mulin et al., 2011), and 30-80 % of 
Alzheimer’s disease (Guimarães, Levy, Teixeira, Beato, & Caramelli, 2008). It is also 
common in amyotrophic lateral sclerosis (ALS), and has been found to be prognostic factor 
for ALS, as it is associated with disability and mortality (Caga et al., 2016). The prevalence of 
apathy is estimated to be around 60% in Traumatic Brain Injury (Starkstein & Pahissa, 2014), 
and often observed in stroke survivors (Brodaty et al., 2005; Hama et al., 2011). Apathy is 
also a common symptom in ‘healthy’ individuals, and becomes more prevalent as people age 
(Mehta et al., 2008). Symptoms of apathy are strongly associated with age in depression, and 
is more common in later-life depression (Groeneweg-Koolhoven et al., 2015). 
Although relatively common, a wide variety of terms have been used to define apathy. 
Van Reekum and colleagues argued that a gold standard for the diagnosis of apathy was still 
needed (Van Reekum, Stuss, & Ostrander, 2005), and that research on apathy might be highly 
clinically relevant for helping informing patients, carers and clinicians (Van Dalen, Van 
Charante, Nederkoorn, Van Gool, & Richard, 2013). Stuss and colleagues argued that in cases 
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where the type of apathy is distinguishable, the rehabilitation and treatment should be tailored 
to address this (Stuss et al., 2000).  
Levy and Dubois (2006) argued that there are three distinct subtypes of apathy: lack of 
initiation of activities; emotionally affective apathy, referring to inability to link behaviours 
with affective and emotional signals; and cognitive apathy, which refers to an inability to 
organise, manage and expand on plans. Several studies have supported these distinctions, 
finding multiple apathy syndromes related with distinct neurological and neuroanatomical 
correlates e.g. (Le Heron, Apps, & Husain, 2017; Starkstein & Leentjens, 2008) 
A consensus in terms of diagnosis was only just reached about ten years ago. A 
taskforce of experienced researchers and clinicians within the field of apathy were consulted 
in 2008 (Robert et al., 2009), to decide upon the diagnostic criteria for apathy. The apathy 
criteria were reviewed in 2018 (Robert et al., 2018). See Table 1 for the diagnostic criteria for 
apathy.  
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Table 1 
Apathy Diagnostic Criteria, retrieved from (Robert et al., 2018) 
CRITERION A 
A quantitative reduction of goal-directed activity either in behavioural, cognitive, emotional 
or social dimensions in comparison to the patient’s previous level of functioning in these 
areas. These changes may be reported by the patient himself/herself or by observation of 
others. 
CRITERION B 
The presence of at least 2 of the 3 following dimensions for a period of at least four weeks 
and present most of the time 
B1. BEHAVIOUR & COGNITION 
Loss of, or diminished, goal-directed behaviour or cognitive activity as evidenced by at least 
one of the following: 
General level of activity: the patient has a reduced level of activity either at home or work, 
makes less effort to initiate or accomplish tasks spontaneously, or needs to be prompted to 
perform them. 
Persistence of activity: He/she is less persistent in maintaining an activity or conversation, 
finding solutions to problems or thinking of alternative ways to accomplish 
them if they become difficult. 
Making choices: He/she has less interest or takes longer to make choices when different 
alternatives exist (e.g., selecting TV programs, preparing meals, choosing from a menu, etc.) 
Interest in external issue: He/she has less interest in or reacts less to news, either good or bad, 
or has less interest in doing new things 
Personal wellbeing: He/she is less interested in his/her own health and wellbeing or personal 
image (general appearance, grooming, clothes, etc.). 
B2. EMOTION 
Loss of, or diminished, emotion as evidenced by at least one of the following: 
Spontaneous emotions: the patient shows less spontaneous (self-generated) emotions 
regarding their own affairs or appears less interested in events that should matter to him/her 
or to people that he/she knows well.  
Emotional reactions to environment: He/she expresses less emotional reaction in response to 
positive or negative events in his/her environment that affect him/her or people he/she knows 
well (e.g., when things go well or bad, responding to jokes, or events on a TV program or a 
movie, or when disturbed or prompted to do things he/she would prefer not to do). 
 
Impact on others: He/she is less concerned about the impact of his/her actions or feelings on 
the people around him/her. 
Empathy: He/she shows less empathy to the emotions or feelings of others (e.g., becoming 
happy or sad when someone is happy or sad, or being moved when others need help). 
Verbal or physical expressions: He/she shows less verbal or physical reactions that reveal 
his/her emotional states. 
B3. SOCIAL INTERACTION  
Loss of, or diminished engagement in social interaction as evidenced by at least one of the 
following: 
Spontaneous social initiative: the patient takes less initiative in spontaneously proposing 
social or leisure activities to family or others. 
Environmentally stimulated social interaction: He/she participates less or is less comfortable 
or more indifferent to social or leisure activities suggested by people around him/her. 
Relationship with family members: He/she shows less interest in family members (e.g., to 
know what is happening to them, to meet them or make arrangements to contact them). 
Verbal interaction: He/she is less likely to initiate a conversation, or he/she withdraws soon 
from it 
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Homebound: He /She prefer to stay at home more frequently or longer than usual and shows 
less interest in getting out to meet people. 
CRITERION C  
These symptoms (A - B) cause clinically significant impairment in personal, social, 
occupational, or other important areas of functioning. 
CRITERION D  
The symptoms (A - B) are not exclusively explained or due to physical disabilities (e.g. 
blindness and loss of hearing), to motor disabilities, to a diminished 
level of consciousness, to the direct physiological effects of a substance (e.g. drug of abuse, 
medication), or to major changes in the patient’s environment. 
 
As seen in the above table, symptoms of apathy might differ, affecting different 
dimensions including behaviour, emotion and social cognition. Radakovic and Abrahams 
provided a useful framework of apathy, by presenting the different dimensions in a 
comparison table. The table from their article is presented in Table 2, as this gives a useful 
overview of apathy dimensions as they are described in the literature.  
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Table 2 
Presents the concepts of multidimensional apathy, retrieved from (Radakovic & Abrahams, 
2018) 
Author 
Dimensions/ 
subtypes 
Definition, symptoms/deficits 
Marin, et al., 
(1991) 
Behavioural 
Decreased productivity, effortful actions, perseverance 
and lack of initiation behaviours. 
Cognitive 
Decreased interest for learning new things, a lack of 
concern for oneself, inability to contribute value to 
recreation, social situations or being productive with 
tasks. 
Affective 
Emotional flatness, lack of responsiveness to emotionally 
charged events (both good and bad) and an emotional 
blunting with unchanging affect 
Cummings et al., 
(1994) 
Initiative 
Spontaneity is reduced for example does not start 
conversations or care about doing new things 
Enthusiasm 
Enthusiasm for and involvement in activities, interests, 
and household chores 
Emotion 
Reduced affect and emotions when compared to the 
individual’s usual self and reduced interest in family 
members or friends 
Robert et al., 
(2002)  
Lack of initiative Reduced conversation and decision making 
Lack of interest 
Reduced interest in hobbies, other people or their family 
members and their interests 
Emotional blunting Reduced affection and emotionally expression 
Sockeel et al., 
(2006) 
Intellectual 
curiosity 
A lack of novelty seeking, interest and motivation along 
with a poor social life. 
Action initiation Unproductive in day-to-day life and lessened initiative 
Self-awareness 
‘Meta-cognitive ability necessary to mediate information 
from a personal, social past and current history with 
projections to the future’ 
Emotion Emotional blunting of responses and diminished concern 
Starkstein & 
Leentjens, (2008) 
Goal-directed 
behaviours 
A lack of energy of effort for daily activities and 
dependence on others for daily structuring 
Goal-directed 
cognition 
A lack of interest in new experiences or in learning new 
things and concern for one’s own well being 
Goal-directed 
behaviour 
concomitants 
Flat affect and emotional unresponsiveness to positive or 
negative occurrences 
Levy, (2012; 
Levy & Dubois, 
(2006) 
Autoactivation 
A lack of activity or initiation of goal-directed thoughts 
and actions, with a particular focus on self-initiation. 
Cognitive 
(Cognitive inertia) 
A lack of ability to expand on plans, organization or 
management of goals 
Emotional 
affective 
Inability to associate behaviours with emotion or affect, 
which extends to the interpretation of affective content 
and therefore experience of extreme affect. 
Radakovic & 
Abrahams, 
(2014) 
Initiation Lack of motivation for self-generation of thought 
Executive 
Lack of motivation for planning, organisation and 
attention 
Emotional 
Lack of emotional motivation, indifference or emotional 
neutrality 
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As seen in the Table 1 and 2, the concept of apathy is complex, encompassing various 
symptoms, and understood through different neurological models. It has been proposed that 
there is a relationship between apathy and damage to prefrontal cortex, paralimbic areas, 
medial prefrontal cortex, anterior cingulate, and anterior temporal cortex, especially the 
amygdala and related subcortical structures (Levy, 2012; Radakovic & Abrahams, 2014). A 
reciprocally connected network model showing the brain regions associated with motivation 
and apathy is presented in Figure 4. This model displays the complexity of involved processes 
(Le Heron, Apps., & Husain, 2018). Damage to any of these areas or pathways may result in 
apathetic symptoms. The observed changes following such damage will inherently present 
different apathetic symptoms.  
Figure 4 
Model of the neuroanatomy for apathy, retrieved from  Le Heron, Apps and Husain, (2018) 
 
Apathy is underrepresented in research considering its negative associations with 
outcomes across patient groups and associations with negative rehabilitation outcomes 
(Konstantakopoulos et al., 2011). Stuss et al., (2000) argued that apathy receives very little 
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attention despite its prevalence as it is often viewed as a secondary symptom following other 
psychiatric or neurological disorders.   
Post-stroke apathy 
Post-stroke apathy (PSAp) is a common neuropsychiatric symptom after stroke 
(Caeiro, Ferro, & Costa, 2013). The prevalence of PSAp varies across studies, with 
prevalence estimates ranging between 22 and 40% (Brodaty et al., 2005; Mikami, Jorge, 
Moser, Jang, & Robinson, 2013). 
PSAp is typically associated with more severe disability and long-term cognitive 
deficits that negatively influence several factors, including quality of life, functional recovery, 
maintaining daily activity, general health (Van Dalen et al., 2013), and chronicity of disability 
(Van Reekum et al., 2005). It is also considered to have a significant social impact and to be 
associated with increased caregiver burden (Van Dalen et al., 2013). Several studies have 
found a positive correlation between apathy scores, cognitive impairment and impairment of 
daily activities (Mikami, et al., 2013), more severe brain dysfunction (Sagen et al., 2010), 
disinhibition (Ricardo, Sergio, & Robert, 2010), and that patients with apathy tend to score 
lower on verbal intelligence (Santa et al., 2008).  
An Australian study found that stroke survivors with apathy had reduced scores on 
attention, concentration, working memory, reasoning, and information processing speed, 
compared with non-apathetic stroke survivors (Brodaty et al., 2005). Individuals experiencing 
PSAp showed less cognitive and physical improvement after six months, compared with 
stroke-patients not experiencing apathy (Mikami et al., 2013). Older age also seems to 
influence apathy scores, as older individuals tend to rate themselves as more apathetic than 
their younger counterparts (Mikami et al., 2013; Sagen et al., 2010; Santa et al., 2008; 
Starkstein, Ingram, Garau, & Mizrahi, 2005).  
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PSAp is considered an independent phenomenon from post-stroke depression (Caeiro 
et al., 2013; Levy et al., 1998). Anhedonia, defined as the inability to feel pleasure, is an 
important symptom of depression recognised in diagnostic criteria (American Psychriatric 
Association, 2013). The distinction between anhedonia in the context of depression and 
apathy can be unclear (Hama et al., 2011). The relationship between apathy and depression is 
complex where lack of interest is a common overlapping feature in both syndromes; whereas 
the aspect of emotionality which is commonly seen in depression, is however considered a 
divergent factor from apathy (Radakovic, 2016).  
Comorbidity between apathy and depression has been observed in about 40 % of the 
cases (Caeiro, et al., 2013; Hackett et al., 2014), which further complicates the distinction. 
Fatigue is a diagnostic symptom of depression and can be associated with apathy. One might 
speculate that these overlaps cause diagnostic challenges. 
Post-stroke apathy and rehabilitation 
PSAp is considered a barrier to treatment in stroke survivors (Mayo, Fellows, Scott, 
Cameron, & Wood-Dauphinee, 2009; Sagen et al., 2010) and has been associated with poorer 
rehabilitation outcomes (Matsuzaki et al., 2015; Van Dalen et al., 2013). Due to its high 
prevalence, and potential interference with the rehabilitation process, it was proposed that the 
evaluation and identification of apathy should be included in acute and follow-up post-stroke 
assessments (Caeiro, et al., 2013).  This will therefore be the focus of this thesis.  
Overall aim for this thesis 
 Given the importance of motivation for stroke rehabilitation and secondary stroke 
prevention interventions, and the potential threat posed by PSAp to stroke recovery and the 
limited literature on PSAp; the overall aims of this thesis are to (1) explore the association 
between PSAp and functional outcomes, and to (2) validate a new, multidimensional measure 
POST-STROKE APATHY    27 
 
of apathy in this population. The validation study will further explore associations between 
apathy, depression and anxiety. Overall findings from both papers will then be discussed and 
concluded in the final chapters.  
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Abstract 
Background: Rehabilitation is highly important to optimise functional outcomes after stroke. 
Apathy, a syndrome characterised by lack of motivation, is prevalent after stroke, bringing the 
risk that rehabilitation and functional outcomes may be affected, due to the lack of 
engagement in rehabilitation. Objectives: This systematic review aimed to investigate the 
association between apathy and functional activity after stroke. The protocol was registered 
on PROSPERO. Method: A systematic search for studies of stroke, apathy and functional 
recovery, published between 1985-2020, was conducted in five databases (Cochrane Library, 
EMBASE, MEDLINE, PsychINFO, and PubMed). Eight articles (N = 1517 stroke-patients) 
were selected for review. The NICE appraisal Checklist was used for quality assessment. A 
second reviewer screened, selected and assessed the risk of bias independently in 20% of the 
articles. Results: Apathy during hospital-based stroke rehabilitation affected functional 
activity negatively in 87.5% of studies reviewed. Apathy was only measured as a 
unidimensional construct. Seven studies were longitudinal (between three months and one 
year) and found that apathy remained relatively stable over time. The total internal validity 
was rated as good in four studies, uncertainties and risks of bias were however identified in all 
studies in terms of external validity. Conclusion: Apathy was common and negatively 
associated with rehabilitation outcomes. Studies used one dimensional measures of apathy, 
which fails to characterise the specific apathy subtype involved.  
Keywords: apathy, apathy screening, stroke, functional recovery, rehabilitation  
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The Association of Apathy and Functional Activities After Stroke: A Systematic Review 
 
Stroke can have a devastating impact, with up to forty percent of stroke survivors 
affected with moderate to severe disabilities (Duncan et al., 2005; Liang, Liang, Ungvari, & 
Tang, 2016). It can have very different functional outcomes and survivors might experience 
changes to their physical, psychological, and social functioning and well-being following a 
stroke (Hackett, Köhler, O’Brien, & Mead, 2014; Hansson, 2004; National Institute for Health 
and Care Excellence [NICE], 2019; Williams et al., 2004). These changes can limit 
independence in functional activities such as dressing, toileting, eating, drinking, mobility 
(walking and use of transport), socialising, hobbies, family responsibilities, housework and 
return to studies or work (NICE, 2019; Rhoda et al., 2014).  
Rehabilitation plays a key role in increasing cognitive, psychological, social, and 
physical functioning and quality of life after stroke (Carod-Artal & Egido, 2009; Kristensen, 
Tistad, Von Koch, & Ytterberg, 2016). With 5% of NHS budgets dedicated to stroke 
treatment and rehabilitation, it is imperative to maximise rehabilitation and optimise outcomes 
(Saka, Mcguire, & Wolfe, 2009). Optimising functional outcomes through stroke 
rehabilitation however, requires effort and motivation on the part of stroke survivors 
(Langhorne, Bernhardt, & Kwakkel, 2011; Rapolienė, Endzelytė, Jasevičienė, & Savickas, 
2018).   
Apathy is common, observed in about one third of stroke survivors (Brodaty et al., 
2005; Caeiro, Ferro, Pinho E Melo, Canhão, & Figueira, 2013; Van Dalen et al., 2013). It is 
defined as a lack of motivation, interest and concern for goal-directed behaviours (Levy & 
Dubois, 2006; Marin, Biedrzycki, Ruth, & Firinciogullari, 1991). The definition of apathy 
varies in the literature, depending on the theoretical model used to understand this concept.  
Apathy is considered a multidimensional construct, with various subtypes or profiles 
(Levy et al., 1998; Marin et al., 1991; Radakovic & Abrahams, 2014; Robert et al., 2009). 
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Differences between apathy subtypes arise as a result of damage to different networks within 
the brain (Le Heron, Apps & Husain, 2018; Levy & Dubois, 2006). There can also be 
differences between the processes affected, which include deficits in choosing to pursue a 
certain behaviour, behavioural perseverance, and the evaluation of the costs and benefits of 
actions (Le Heron, et al., 2018).  
Post Stroke Apathy (PSAp) is associated with damage to the brain, particularly to the 
prefrontal lobes, subcortical structures and basal ganglia systems (Levy & Dubois, 2006). 
Apathy can reduce motivation for participation in stroke rehabilitation and can be very 
disabling (Cosin et al., 2015; Mayo et al., 2015). If apathy is related with poorer outcomes, 
then this is of high clinical relevance and should be routinely screened for in stroke-
populations. Given its prevalence, apathy has not received adequate attention in research 
(Hama, Yamashita, Yamawaki, & Kurisu, 2011; Sagen et al., 2010).  
To our knowledge, there is currently no systematic review focusing on PSAp and its 
effect on functional outcomes in stroke rehabilitation. The focus of this systematic review is 
therefore to examine the association between apathy and functional activity following a 
stroke. We investigated if apathy affects functional activity and if so, how much, when and 
how does it affect some activities more than others? The focus will be on outcomes for people 
following a stroke instead of comparing specific interventions. 
Methods 
For this systematic review we investigated the association between apathy and 
functional activities after a stroke. Figure 1 presents our PICO definition, which helps to 
specify the research question by identifying (1) the Patient problem or Population, (2) the 
Intervention, (3) the Comparison, and (4) the Outcome(s) (Cooke et al., 2012). The primary 
outcomes were associated with level of functional activity after a stroke. 
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Figure 1 
Our PICO Definition based on Cooke et al., (2012). 
P 
Does post-stroke apathy occur in adult 
stroke survivors 
I 
Undergoing acute or community-based 
stroke rehabilitation 
C - No comparison -  
O Affect recovery of functional activities 
P= Population/problem, I= Intervention, C= 
Comparison, O= Outcome 
 
We included studies with stated outcome measures for functional activity, such as The 
Barthel Index (Collin, Wade, Davies, & Horne, 1988; Mahoney & Barthel, 1965), and 
Functional Independence Measure (Linacre, Heinemann, Wright, Granger, & Hamilton, 
1994).  
We decided not to limit research based on their dimensional understanding of apathy. 
Apathy was measured using screening tools such as the Apathy Evaluation Scale (Marin et 
al., 1991), and the Apathy Inventory (Robert et al., 2002). Studies without any form of formal 
assessment of apathy were excluded from this systematic review. 
There is agreement in terms of what constitutes a stroke, but there are differences 
when it comes to level of detail (neuroanatomical information, severity, frequency, age etc). 
We decided not to make restrictions in terms of stroke type, location or severity, given that it 
was indicated that literature in this area is scarce.  
Search strategy 
The systematic review protocol was registered on Prospero 
(https://www.crd.york.ac.uk/prospero/), which is sponsored by the National Institute for 
Health Research, UK. The PRISMA Guidelines (Moher et al., 2009), were used to guide the 
search strategy (see Figure 2). Four electronic bibliographic databases were searched: 
MEDLINE (Ovid), EMBASE (Ovid), PsycINFO (EBSCO), PubMed (EBSCO) and the 
POST-STROKE APATHY    44 
 
Cochrane Library. Studies published from 1985 onwards were included. Restrictions were 
applied to include only primary research, studies with human samples, in the English 
language, published in peer reviewed journals. Single case-studies, opinion articles and 
conference abstracts where the full text was not available were excluded.  
A mixture of keywords and Medical Subject Headings (MeSH) was used to identify 
terms. The search terms used were: Apath* OR Amotivation OR Diminished motivation OR 
Avolition OR Athymhormia OR Indifference AND Stroke OR Ischemi* OR Infarct* OR 
Hemorrhag* OR Thrombo* OR Emboli* OR Cerebrovascular AND Functional Activity OR 
Recovery of function OR Recovery OR Improvement OR Functional recovery.  
Data analysis 
A narrative synthesis was carried out focusing on functional recovery in relation to 
apathy. Functional activity was the primary outcome measure. It was expected that 
publications in this area would be limited given the preliminary search conducted before the 
formal data search and extraction. A narrative synthesis was planned as meta-analysis was 
unlikely to be possible. Data were handled using reference manager Zotero and imported to 
Microsoft Excel. The studies were appraised using the NICE Appraisal Checklist. No formal 
statistical analysis was conducted. 
Study Selection 
All searches were carried out on 4th February 2020. The primary reviewer screened 
titles and abstracts. As advised by the PRISMA guidelines (Moher et al., 2009), a secondary 
reviewer screened titles and abstracts of 20% of articles and inclusion and exclusion were 
compared between reviewers. There were no issues in terms of agreement, as reviewers 
agreed in all cases. All articles meeting the inclusion criteria were examined using the quality 
assessment tool by both reviewers.   
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Information about study design, type of stroke, number of participants, measures and 
results was extracted. The screening process is visually presented in the flowchart below.  
Quality Appraisal and Risk of Bias 
Study quality was assessed using the NICE Quality Appraisal Checklist (see Appendix 
C), developed to support evaluation of the internal and external validity of correlational 
studies, in terms of study design, population, method, outcomes and analyses (NICE, 2012). 
These aspects of study quality are rated using five possible responses: 1) ++ indicates the 
study is designed to minimise risk of bias, 2) + indicates information is not clearly reported, 
3) - indicates a significant source of bias, 4) Not reported (NR) indicates the study failed to 
report an aspect of methodology and lastly, 5) Not applicable (NA), where the section does 
not apply to the study due to study design (NICE, 2012). Studies are not given an overall 
numerical score in this checklist.  
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Results 
Eight studies were identified for review following the searches, see Table 1 for 
summary.  
 
Figure 2 
Prisma flowchart 
 
 
 
Figure 1. Prisma Flowchart
Records identified through database 
searching 
(n =   3010) 
S
cr
ee
n
in
g
 
In
cl
u
d
ed
 
E
li
g
ib
il
it
y
 
Id
en
ti
fi
ca
ti
o
n
 
Records after duplicates removed 
(n =   2860) 
Records screened 
(n = 98) 
Records excluded 
(n = 84) 
Full-text articles 
assessed for eligibility 
(n = 14) 
Full-text articles excluded 
(n = 6) 
No measure of functional activity 
(n= 3) 
Not primary research (n= 1) 
Exploring motivation, excluding 
apathy (n= 1) 
Different population, SAH and 
TIA (n= 1)  
 
Studies included in 
qualitative synthesis 
(n = 8) 
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Table 1 Summary of all 8 studies reviewed   
            
Author Relevant Study 
Aims 
Sample size Age  
Mean 
(SD) 
Females 
(%) 
Type of stroke Study design Apathy 
Measure 
Functional 
Activity 
measure 
Relevant Findings 
1. Bickerton et 
al., 2015 
To examine the 
utility of the BCoS 
in discriminating 
cognitive profiles 
and recovery of 
function across 
stroke survivors. 
657 Stroke 
patients (331 
were 
reassessed 
after 9 
months),100 
matched 
controls.  
69.31 
(14.34) 
 
43.29 Left (152) vs. 
right hemisphere 
(181) strokes as 
well as first ever 
(455) vs. 
repeated strokes 
(202) 
Observational, 
Cross-sectional 
study 
AES-S NEADL, BI  Functional outcome at 
9 months correlated 
with domain-level 
deficits in controlled 
attention, spatial 
attention, and praxis 
over and above initial 
dependency and 
concurrent levels of 
affect and apathy. 
 
2. Hama, et al., 
2007 
To examine the 
effect of apathy on 
functional recovery 
after stroke 
237 Stroke 
patients  
65.1 
(11.3) 
 
34.2 Ischemic (128) 
and 
haemorrhagic 
(109) 
Observational, 
Cross-sectional 
study 
AS, NPI  FIM Apathy correlated 
negatively with 
improvement in FIM 
after stroke.  
3. Hama, et al., 
2008 
To examine the 
effect of acceptance 
of disability or 
'insistence on 
recovery' in stroke 
patients: first on 
their functional 
improvement and 
second, on their 
psychological 
symptoms. 
 
 
 
 
237 Stroke 
patients  
66.3 
(10.2) 
 
29.87 Ischemic (136) 
and 
haemorrhagic 
(95) 
Observational, 
Cross-sectional 
study 
AS FIM “Insistence on 
recovery reduced 
apathy, resulting in 
enhanced 
improvement of 
disability after a stroke 
in elderly stroke 
patients.” AS scores 
decreased as insistence 
on recovery score 
increased.  
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Table 1 Continued 
Author Relevant Study 
Aims 
Sample size Age  
Mean 
(SD) 
Females 
(%) 
Type of stroke 
 
Study design Apathy 
Measure 
Functional 
Activity 
measure 
Relevant Findings 
4. Harris, Elder, 
Schiff, Victor & 
Goldfine, 2014 
To examine the 
effect of apathy and 
hypersomnia on 
outcome in acute 
rehabilitation.  
213 Stroke 
patients  
78.1 
(range: 
73.5-84) 
 
59 Haemorrhagic 
stroke control 
patients  
Cross-sectional 
design 
(retrospective) 
Correlational 
Clinical 
diagnosis 
of apathy/ 
modified 
version of 
AS 
FIM Patients with apathy 
were 2.4 times more 
likely to go to a 
nursing home and had 
discharge FIM scores 
12 points below the 
mean compared with 
non-apathetic stroke 
survivors. 
 
5. Kennedy, 
Granato & 
Goldfine, 2015 
To determine how 
the severity of 
apathy changes in 
the first weeks after 
stroke.  
257 Stroke 
patients  
72.8 
(13.9) 
Not stated Ischemic and 
Haemorrhagic 
stroke, where 
21% had 
persistent apathy 
Observational, 
Cross-sectional 
study 
AI-C FIM Apathy was present in 
28% of patients 
undergoing inpatient 
acute rehabilitation for 
stroke. Apathy 
improved only 
modestly during the 
acute rehabilitation 
stay, and the majority 
of patients with apathy 
remained still had 
apathy at discharge. 
 
6. Mikami, Jorge, 
Moser, Jang & 
Robinson, 2013 
To examine the 
course of cognitive, 
physical, and social 
impairment among 
patients who 
developed apathy 
during the first year 
after stroke. 
 
 
 
56 Stroke 
patients, 
(compared 
apathy vs. no 
apathy) 
No apathy 
62.1 
(12.3), 
apathy 
66.5 
(14.9) 
No apathy 
36.6, 
apathy 
34.8 
Ischemic (no 
apathy 84.8, 
apathy:100) and 
haemorrhagic (no 
apathy: 15.2, 
apathy:0) 
Observational, 
prospective 
cohort study 
"Clinical 
diagnosis 
of apathy" 
and/or a 
modified 
version of 
AS 
FIM, SFE Apathy associated 
with less recovery in 
cognition and ADLs 
over the first year after 
stroke compared with 
similar non-apathic 
patients. 
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Table 1 Continued 
Author Relevant Study 
Aims 
Sample size Age  
Mean 
(SD) 
Females 
(%) 
Type of stroke 
 
Study design Apathy 
Measure 
Functional 
Activity 
measure 
Relevant Findings 
7. Santa, et al., 
2008 
To examine the 
frequency of apathy 
after a first-ever 
stroke and to 
prospectively study 
the impact of apathy 
on functional 
recovery. 
67, Stroke 
patients, 
measured at 
hospital 
admission 
and three 
months after 
stroke 
(apathy vs. no 
apathy) 
 
Apathy 
70.4 (2.6) 
no apathy 
64.1(1.4) 
Apathy 
50, no 
apathy 42 
Ischemic 
(Apathy: N=11, 
no apathy N= 24) 
and 
haemorrhagic 
(Apathy: N=3, no 
apathy N= 29) 
Observational, 
prospective 
cohort study 
AS  BI, FIM Apathetic patients 
showed less 
improvement in the 
Barthel index or 
scores of functional 
independence 
measures than 
nonapathetic patients 
after rehabilitation. 
 
8. Skidmore, 
Whyte, Butters, 
Terhorst & 
Reynolds, 2015 
To examine the 
effects of strategy 
training, a 
behavioural 
intervention used to 
augment usual 
inpatient 
rehabilitation, on 
apathy symptoms 
over the first 6 
months after stroke. 
30 Stroke 
patients in 
acute 
inpatient 
rehabilitation. 
Strategy 
training vs 
usual 
inpatient 
rehabilitation. 
Admission, 3- 
and 6-months 
follow-up. 
 
  
Strategy 
training 
group 
64.87 
(16.59), 
reflective 
listening 
71.80 
(13.19) 
Strategy 
training 
groups, 
males: 9 
(60), 
reflective 
listening 
11 (73) 
Strategy training 
Ischemic (19 
(67), reflective 
listening, 11(73), 
Hemisphere right 
strategy training 
10 (67), 
reflective 
listening 11 (73)  
Secondary 
analysis of 
randomised 
control trial 
AES (self-
rating) 
FIM Correlations between 
apathy and function 
independence scores 
were nonsignificant, 
either at the 3-month 
or 6-month follow-up* 
AES= Apathy Evaluation Scale (Marin et al., 1991), AI=Apathy Inventory (Robert et al., 2002), AS= Apathy Scale (Starkstein et al., 1992), BCoS= Birmingham 
Cognitive Screen (Bickerton et al., 2015), BI= Barthel Index (Mahoney & Barthel, 1965), FIM= Functional Independence Measure (Hamilton et al., 1994), MHLC= 
Multidimensional Health Locus of Control (Wallston, Wallston, & Devellis, 1978), NPI-NH= Neuropsychiatric Inventory-Nursing Home (Lange et al., 2004), 
NEADL=Nottingham Extended Activities of Daily Living (Nouri & Lincoln, 1987), PSD= Post-stroke depression, SFE= Social Functioning Exam (Starr, Robinson, & 
Price, 1983). *Data were provided by the authors upon request and not past of the published article 
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Quality assessment - External validity  
As seen in Table 2, there were issues with external validity in all studies. All studies 
showed lack of information in terms of source population, and there is risk of bias in terms of 
generalisability and external validity. Five studies named the hospitals where data was 
collected (Hama et al., 2008, 2007; Harris et al. , 2014; Kennedy, Granato, & Goldfine, 2015; 
Mikami, Jorge, Moser, Jang, & Robinson, 2013; Santa et al., 2008), more detailed information 
about the sourcing of participants was however not provided.  
There was generally little diversity in terms of location, with four studies conducted in 
the United States (Harris et al., 2014; Kennedy et al., 2015; Mikami et al., 2013; Skidmore, 
Whyte, Butters, Terhorst, & Reynolds, 2015), three in Japan (Hama et al., 2008, 2007; Santa 
et al., 2008) and one in the United Kingdom (Bickerton et al., 2015).  
Quality assessment – Internal validity 
As seen in Table 2, four of the eight studies were rated as having good internal validity 
based on the NICE quality appraisal checklist (NICE, 2012). All studies were based on 
observational data, with the exception of one study examining secondary data from a 
randomised controlled trial (RCT) (Skidmore et al., 2015). Only one study was rated as good 
in terms of theoretical basis of explanatory variables (Bickerton et al., 2015). Two studies 
provided sufficient psychometric information regarding their measures (Mikami et al., 2013; 
Skidmore et al., 2015), the remaining studies did not provide sufficient information. Only 
three studies sufficiently reported all important outcomes (Bickerton et al., 2015; Kennedy et 
al., 2015; Mikami et al., 2013).  
In terms of follow-up time, three studies were rated as good (Hama et al., 2008; 
Mikami et al., 2013; Skidmore et al., 2015), follow-up time was too short in four of the 
studies (Bickerton et al., 2015; Harris et al., 2014; Kennedy et al., 2015; Santa et al., 2008). 
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All findings are summarised in Table 2, see Appendix C for more details about quality 
ratings.   
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Table 2  
Summary of quality assessment of the 8 included studies, based on the NICE Quality Appraisal Checklist. Scoring key is available 
in Appendix B. 
  Population Method   Outcomes       Analyses Summary 
Study 1.1 1.2 1.3 2.1 2.2 2.3 2.4 2.5 3.1 3.2 3.3 3.4 3.5 4.1 4.2 4.3 4.6 
Total 
Internal 
Validity 
Total External Validity 
1. Bickerton, et 
al., 2015 + - + NA ++ NA ++ NR + + ++ ++ + ++ ++ ++ ++ ++ + 
2. Hama, et al., 
2007 + ++ + NA + NA + NR + NA + NA NA ++ ++ NA ++ ++ + 
3. Hama, et al., 
2008 + + + NA + NA + NR + + + NA ++ ++ ++ + + + + 
4. Harris, et al., 
2014 + + ++ NA + NA + NR + NA + ++ + ++ ++ ++ ++ + + 
5. Kennedy, et 
al., 2015 + ++ + NA + NA ++ NR + + ++ ++ + ++ ++ + + + + 
7. Mikami, et al., 
2013 + ++ + NA + NA ++ NR ++ NA ++ NA ++ + ++ ++ - ++ + 
8. Santa, et al., 
2008 + + + NA NA NA + NR + NA + NA + - + + + + + 
9. Skidmore, et 
al., 2015 + + + + + + + NR ++ NA + ++ ++ + ++ ++ ++ ++ + 
++ indicates that for that particular aspect of study design, the study has been designed or conducted in such a way to minimise the risk of bias. + indicates 
that either the answer to the checklist question is not clear from the way the study is reported, or that the study may not have addressed all potential sources 
of bias for that particular aspect of study design. - should be reserved for those aspects of the study design in which significant sources of bias may persist. 
NR not reported should be reserved for those aspects in which the study under review fails to report how they have (or might have) been considered. NA not 
applicable should be reserved for those study design aspects that are not applicable given the study design under review.  
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Summary of Findings 
Table 1 provides an overview of study aims, participant demographic information and 
main findings. As seen in Table 1, studies tended to focus on stroke patients in relatively early 
interventions at rehabilitation hospitals. Patients were assessed whilst admitted to acute 
rehabilitation hospital wards (Bickerton et al., 2015; Harris et al., 2014; Kennedy et al., 2015; 
Santa et al., 2008; Skidmore et al., 2015), or within less than three months after stroke (Hama 
et al., 2007; Hama et al., 2008; Mikami et al. 2015). A few studies also included a follow-up 
assessments 3 months after the initial point of assessment (Harris et al., 2014; Mikami et al. 
2013; Santa et al., 2008; Skidmore et al., 2015), 6 months (Mikami et al. 2013; Skidmore et 
al., 2015), 9 months (Bickerton et al., 2015; Mikami et al. 2013), and one year after the 
baseline assessment (Mikami et al. 2013). 
Two studies focused on how people with elevated apathy scores performed in 
activities of daily living (ADLs) at various times during hospitalisation compared with stroke 
patients without apathy (Mikami et al., 2013; Santa et al., 2008). ADLs refer to essential skills 
needed for independent self-care, including eating, grooming, dressing, toileting and mobility 
(Mlinac & Feng, 2016).  Some studies focused on acute rehabilitation (Hama et al., 2008, 
2007; Harris, Elder, Schiff, Victor, & Goldfine, 2014; Kennedy et al., 2015), whereas others 
had a longer follow-up period (Bickerton et al., 2015; Mikami et al., 2013; Santa et al., 2008). 
One study used secondary data from an RCT to investigate a new form of treatment targeting 
symptoms of apathy (Skidmore et al., 2015).  
Assessment of apathy 
The most frequently used screening tool was the self-rated version of the Apathy Scale 
(Starkstein, Mayberg, Andrezejewski, Leiguarda, & Robinson, 1992), which was used by four 
of the studies (Hama et al., 2008, 2007; Harris et al., 2014; Santa et al., 2008), see Table 1. 
One study (Hama et al., 2007) also used the Neuropsychiatric Inventory (Lange, Hopp, & 
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Kang, 2004), as an observer-rated measure for comparison with the self-rated score. Both AS 
and NPI give unidimensional apathy scores. One study (Mikami et al., 2013) based their 
apathy assessments on a modified clinician rated version of the AS, as well as clinical 
diagnosis. Diagnosis was based on the Robert et al., (2009) criteria for Alzheimer’s disease. 
Harris et al., (2015) also based some of their apathy assessment on diagnosis. A diagnosis was 
given if patients were described in accordance with apathy descriptions by physical and 
speech and language therapists during rehabilitation. Finally, one study (Kennedy et al., 2015) 
used the clinician-rated version of the Apathy Inventory (Robert et al., 2002), which is a 
multidimensional measure. Findings were however presented based on the total scores; 
subscale scores were not presented.  
Assessment of Functional Activity 
The Functional Independence Measure (FIM, Hamilton, Laughlin, Fiedler, & Granger, 
1994) was the most frequently used measure of functional activity, used by seven of the eight 
studies, (Hama et al., 2008, 2007; Harris et al., 2014; Kennedy et al., 2015; Mikami et al., 
2013; Santa et al., 2008; Skidmore et al., 2015). The FIM is considered valid and reliable and 
is commonly used in clinical practice (Duncan et al., 2005). It is important to bear in mind, 
however, that this scale is not uniform or linear in terms of changes in the upper and lower 
extremes, as these represent different functional improvements (Harris et al., 2014). Two 
studies (Bickerton et al., 2015; Santa et al., 2008) used the Barthel Index (Collin et al., 1988).  
Association between Post-Stroke Apathy and Functional Activity 
Apathy was negatively associated with functional outcome after stroke in all the 
reviewed studies indicating that stroke survivors with apathy have worse prognosis in terms of 
recovery. Apathy was prevalent, ranging between  28 and 44% in the samples across studies, 
and they were found to remain relatively stable throughout rehabilitation, (Hama et al., 2008, 
2007; Kennedy et al., 2015; Matsuzaki et al., 2015; Mikami et al., 2013; Santa et al., 2008).  
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Two studies found that stroke survivors with apathy were more than twice as likely to 
be discharged to a nursing home following hospitalisation (Harris et al., 2014; Kennedy et al., 
2015). Although at a slower pace, improvements were also observed in stroke survivors with 
apathy, and it was suggested that all patients benefit from rehabilitation in terms of 
improvement of functional activities even when not being fully able to utilise the full potential 
of treatment (Matsuzaki et al., 2015; Santa et al., 2008).  
Self-Report Measures 
Five studies used self-rated apathy measures (Table 1). One of the studies, which also 
included the NPI as an observer-rated measure, found a significant difference between apathy 
scores (Matsuzaki et al., 2015). In this study, an additional eleven percent of the sample 
reached the threshold of a clinical diagnosis of apathy when rated by the clinician compared 
with self-rated scores (Matsuzaki et al., 2015). Unfortunately, the other study did not directly 
investigate the relationship between the observer- and self-rated scores, as the AS was only 
used in the follow-up analysis (Hama et al., 2007). The study using the clinician rated form 
(AI-C) chose this scale to include patients with aphasia and did not include a self-rated scale 
for comparison (Kennedy et al., 2015). 
A concern was raised by two studies (Harris, 2014; Matsuzaki et al., 2015), regarding 
the apathy prevalence in stroke research, as scores are thought to be grossly underestimated. 
The use of self-rated scales on their own was criticised, due to limitations in terms of personal 
awareness following stroke. Both studies pointed to clinician rated versions of the scales as 
more reliable methods when assessing apathy.  
Two studies argued that the use of self-report in research is potentially problematic 
since it might exclude stroke survivors with aphasia (Harris, et al., 2014; Kennedy et al., 
2015). One study found that patients with aphasia are much more likely to experience apathy 
symptoms compared with stroke patients not experiencing language impairments (Harris, et 
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al., 2014). This finding was echoed by Kennedy and colleagues (2015), who also found a 
strong correlation between aphasia and apathy. 
Apathy and Stroke Characteristics  
Four studies included stroke characteristics in their analyses. An interesting finding 
was that hypersomnia and apathy, but not stroke severity was associated with poorer 
outcomes (Harris et al., 2014). One study found significant differences between apathy and 
repeated strokes, and that people suffering from multiple strokes had worse symptoms than 
people who had only experienced one stroke (Bickerton et al., 2015). Another finding from 
the same study was that apathy was more frequent in patients with damage to the right 
hemisphere than those with left hemisphere strokes. One study found that apathy was more 
prevalent in ischaemic strokes compared with haemorrhagic strokes, and that ischemic strokes 
were associated with poorer outcomes (Santa et al., 2008).  
Post-stroke Apathy, Age and Functional Activities 
There were inconsistencies in the association between apathy and confounding 
variables. Two studies found that older patients were significantly more apathetic (Santa et 
al., 2008), as well as being more cognitively impaired (Mikami et al., 2013). Another study 
found no significant association between apathy scores and age, days since stroke onset or 
years of education (Kennedy et al., 2015).  
Timing of Apathy Assessment 
Almost all reviewed studies included a follow-up assessment of apathy in their 
research whilst patients were at hospital. None of the studies, however, followed patients 
longer than a year after stroke or provided post discharge follow-up assessments.
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Discussion 
This systematic review examined the association between PSAp and functional 
outcomes, identifying eight studies for analysis. This is not numerous considering the 
immense cost and patient and caregiver burden associated with stroke (Saka et al., 2009; Van 
Dalen et al., 2013), especially considering that about one third of stroke survivors experience 
apathy in the first year (Bickerton, et al., 2015; Hama, et al., 2007; Skidmore, et al., 2015). 
Quality assessment showed that there were issues in terms of the external validity of all the 
reviewed studies. This suggests that generalisability of findings cannot be assumed. Half of 
the studies had good internal validity, whilst there were uncertainties in relation with risk of 
bias in the remaining four.  
Findings from this systematic review indicate that apathy was associated with poorer 
functional outcomes following stroke and remained relatively stable throughout rehabilitation. 
Stroke survivors with apathy were more likely to be discharged to nursing homes than 
survivors without apathy (Harris et al., 2014). Although at a slower pace, the studies reviewed 
found that stroke patients with apathy benefitted from rehabilitation and showed 
improvements on functional outcomes (Santa et al., 2008). 
It is important to identify realistic goals in rehabilitation, to support and optimise 
functional recovery and quality of life (Dobkin, 2004).  There are currently no evidence-based 
treatments targeting PSAp, and it is therefore important to gain better insight into this 
syndrome (Kennedy et al., 2015).  It has been argued that it is the clinician’s responsibility to 
test adjunct strategies on patients with apathy symptoms before concluding that there are no 
further gains to be made (Dobkin, 2004).  
Six of the studies used unidimensional measures for apathy, which do not distinguish 
between apathy subtypes. This is problematic as apathy is considered a multidimensional 
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construct, with impairments in behavioural emotional and social interaction (Robert et al., 
2018). The two studies (Bickerton et al., 2015; Skidmore et al., 2015) using multidimensional 
measures, did not fully utilise the potential of these, as they were only reporting severity of 
the total scores, and apathy profiles were not provided. This is a major issue, as apathy 
research indicates that there are distinct types of apathy associated with specific brain regions 
and pathways (Le Heron et al., 2017; Marin et al., 1991;Stuss, van Reekum, & Murphy, 
2000). Post-stroke profiles of apathy would provide clinically relevant information informing 
rehabilitation planning. For example, a stroke survivor with initiation apathy might need 
different support to someone with emotional apathy. We predict that apathy subtype might be 
associated differently with functional outcomes.  
In terms of prevalence, apathy was present in 28-44 % of stroke survivors, which 
concurs with PSAp literature, e.g. (Caeiro, Ferro, e Melo, Canhão, & Figueira 2013; Hollocks 
et al., 2015; Jorge, Starkstein, & Robinson, 2010), showing that apathy is common after 
stroke. The prevalence of apathy is much higher when also considering the more impaired 
part of the stroke population, compared with less impaired counterparts, as well as when 
considering issues concerning insight (Matsuzaki et al., 2015).  
An identified difficulty with self-report measures of apathy, is that this sampling 
method does not allow access to a diverse and representative sample of real-life stroke 
populations. There are many stroke survivors living with severe cognitive impairments and 
aphasia that would struggle using these measures (Santa et al., 2008). This has also been 
previously raised in the literature on PSAp (Caeiro, et al., 2013). The use of self-report 
measures does however require less resource in terms of clinician time and training and is 
considered a non-intrusive form of data collection in terms of patient burden (Matsuzaki et al., 
2015).  Neither the AES-S (Marin et al., 1991), AS (Starkstein et al., 1992), NPI (Lange et 
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al.,2004) or AI (Robert et al., 2002), have been specifically validated for stroke. We argue that 
self-rating can still be useful as an apathy assessment – 
the self-rated Dimensional Apathy Scale (Radakovic & Abrahams, 2014) has been utilised 
and validated in dementia patients, a group that is typified by cognitive impairment, and 
showed self-rated apathy/motivational impairments compared to controls (Radakovic, 
Davenport, Starr, & Abrahams, 2018).  
Apathy is often evaluated later than other consequences of stroke, usually around three 
months after stroke (Cosin et al., 2015), which was also found to be the case in our review. 
People who had no apathy in the first week following stroke generally did not develop apathy 
at later points (Kennedy et al., 2015). Apathy can however develop or worsen in a few cases 
over time, and should be assessed and monitored throughout the intervention (Kennedy et al., 
2015). It has been argued that there is no need to delay apathy assessment as apathy has been 
shown to be relatively stable and present at earlier stages of recovery (Cosin et al., 2015). By 
delaying early assessment of apathy, there is a risk of reducing the efficiency of early 
intervention. 
In the reviewed articles, there were inconsistent findings regarding associations 
between demographic information such as age, education level and gender with apathy. The 
association of age and apathy with functional activity therefore remains unclear. Age has been 
found to be associated with greater cognitive impairments and apathy in other research (Sagen 
et al., 2010; Starkstein, Ingram, Garau & Mizrahi, 2005).  
A study not included in the review, as it focused on Subarachnoid haemorrhage and 
TIA rather than stroke, found that apathy had a negative influence on outcome in terms of 
functional activities after transient ischemic attack or subarachnoid haemorrhage (Matsuzaki 
et al., 2015).  
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Strengths, limitations and future directions 
It has been argued that stroke rehabilitation differs between healthcare systems, 
highlighting the importance of considering contextual differences in the evaluation of stroke 
rehabilitation programmes (Putman & De Wit, 2009). Most of the studies included in our 
review were conducted in hospitals in the USA and Japan. It is possible that hospital practices 
in these countries differ from UK and Europe. Another point is that none of the studies 
provided follow-up assessment beyond one year of treatment, it would be interesting to gain 
greater knowledge of the stability of PSAp exceeding this timeframe.  
There are some concerns in terms of apathy assessment and prevalence. It is 
problematic that researchers base their understanding of apathy upon different models (some 
viewing apathy as a symptom of depression, others as a separate neurological syndrome). This 
is especially problematic when reviewing apathy based on clinical expertise from medical 
records, as there are several layers of nuances potentially lost in the translation of these 
transcripts. Research focusing on differential apathy diagnostics, including apathy subtypes 
and severity would be a valuable contribution and clinically relevant to PSAp research. 
Conclusion 
Despite the high prevalence of apathy, only eight studies were identified for review. 
Study quality was assessed with the NICE appraisal checklist. Interval validity was assessed 
as good in four studies. There were issues in terms of external validity in all studies. To 
conclude, apathy was commonly reported in these samples, with about one third of stroke 
patients above clinical thresholds of apathy across studies (Bickerton et al., 2015; Hama, et 
al., 2007; Mikami et al., 2013; Skidmore et al., 2015). The overall findings supported that 
apathy is associated with delayed recovery of functional activity. Studies frequently used self-
report-based scales when screening for apathy, and limitations regarding language problems 
POST-STROKE APATHY   61 
 
and insight were raised and discussed. Patients with apathy benefit from rehabilitation 
programmes, even when apathy is not specifically targeted.  
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Bridging the Systematic Review and Empirical Paper 
 
The systematic review (SR) explored the association between post-stroke apathy 
(PSAp) and functional outcomes in stroke rehabilitation, finding a negative relationship 
between these. Stroke survivors with apathy were 2.4 times more likely to move to a nursing 
home following discharge compared with survivors without apathy (Harris et al., 2014). 
Optimising outcome in terms of functional activities after stroke is important, as this allows 
functional autonomy and social inclusion as the stroke survivor is able to look after his or 
herself and their home independently, return to work, studies, parenting etc. (Campos et al., 
2019). 
Despite the high prevalence of PSAp and its association with poor rehabilitation 
outcomes, the assessment of apathy is often delayed or absent in clinical settings (Cosin et al., 
2015). It is also noteworthy that there are currently no recommendations or mention of PSAp 
in the NICE guidance on stroke (Royal College of Physicians, 2016).  
The most frequently used apathy measure in the SR was the self-rated version of the 
Apathy Scale (Starkstein, Mayberg, Andrezejewski, Leiguarda, & Robinson, 1992), which 
provides a unidimensional apathy score. Apathy was also assessed using the Neuropsychiatric 
Inventory, NPI (Cummings et al., 1994), which has only a single item on apathy. Here, apathy 
is scored on a dichotomous yes/no basis, and does not provide nuances such as severity or 
elaboration in terms of apathy subtype (Robert et al., 2002). One study used a 
multidimensional measure in the SR: the clinician-rated version of the Apathy Inventory 
(Robert et al., 2002). The potential of the apathy subscale scores was however not used to 
characterise the nature of the apathy involved.  
As discussed in the introduction chapter, apathy can present in different ways and is 
understood as a multifaceted syndrome: affecting constructs such as initiation (Cummings et 
al., 1994; Robert et al., 2002; Stuss, van Reekum, & Murphy, 2000), affect (Cummings et al., 
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1994; Marin et al., 1991), goal-directed behaviours (Levy & Dubois, 2006; Starkstein & 
Leentjens, 2008), and intellectual curiosity and self-awareness (Sockeel et al., 2006). These 
constructs are associated with focal damage to different areas and pathways. Despite the 
prevailing view that apathy is a multidimensional phenomenon,(Le Heron et al., 2017; Levy, 
2012; Radakovic & Abrahams, 2014; Robert et al., 2018) researchers are still relying on 
unidimensional measures, such as the Apathy Scale (Starkstein et al., 1992), as highlighted in 
the SR (Bickerton et al., 2015; Hama et al., 2008, 2007; Harris et al., 2014; Mikami et al., 
2013; Santa et al., 2008; Skidmore et al., 2015). 
Apathy Subtypes and Assessment  
Levy and Dubois (2006) mapped their understanding of apathy on to Stuss’ model for 
executive functioning (Stuss & Alexander, 2000), and proposed that there are three main 
apathy subtypes: lack of initiation of activities, emotionally affective apathy, and cognitive 
apathy - which refers to an inability to organise, manage and expand on plans (Levy & 
Dubois, 2006).  
The Dimensional Apathy Scale, (DAS, Radakovic & Abrahams, 2014) was developed 
to provide a multidimensional assessment of apathy based on the neurocognitive model of 
Levy and Dubois (2006). It consists of three subscales. The executive subscale of the DAS 
(e.g. item 17 “When doing a demanding task, I have difficulty working out what I have to 
do”) maps onto the cognitive apathy subtype in the Levy and Dubois model. This type of 
apathy could potentially affect functional outcome of stroke rehabilitation as patients may not 
be able to set or follow rehabilitation goals. The cognitive, behavioural and initiation subscale 
on the DAS maps onto Levy and Dubois’s auto-activation subtype, focusing on behaviour, 
initiation and thoughts. “I try new things” is a reverse-scored item measuring this domain 
(Radakovic & Abrahams, 2014). Patients with this type of apathy may not initiate 
rehabilitation tasks. The emotional apathy subscale of the DAS refers to the integration of 
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emotional behaviour, where the outcome of this can be emotional blunting, neutrality and 
indifference (Radakovic & Abrahams, 2014). An example from the emotional apathy subscale 
on the DAS is “I feel indifferent to what is going on around me”. Each subscale consists of 8 
items. Here patients may not be able to feel concern about their rehabilitation. 
The DAS has been validated for use with people with neurogenerative disorders, such 
as Alzheimer’s Disease, Parkinson’s and Amyotrophic Lateral Sclerosis (ALS), (Radakovic & 
Abrahams, 2014, 2018; Radakovic, Stephenson, et al., 2016), but not for use with stroke 
survivors. For Parkinson's disease and Alzheimer’s Disease, the executive and initiation 
apathy subtypes of the DAS were most prominent (Radakovic et al., 2018; Radakovic, 
Stephenson, et al., 2017), whereas initiation apathy was the most prominent subtype for 
Amyotrophic lateral sclerosis (Radakovic, Stephenson, et al., 2016). The emotional apathy 
subtype was less prominent across all three conditions. The emotional apathy subtype has 
been found to be more prevalent in frontotemporal dementia compared with Alzheimer’s 
disease (Radakovic, Colville, et al., 2016; Wei, Irish, & Hodges, 2020). These findings 
suggest that apathy profiles vary across neurological conditions.   
 The validation of instruments prior to use in clinical practice and research is important 
to ensure they provide valid and reliable measures of the concepts targeted (Meader, Moe-
Byrne, Llewellyn, & Mitchell, 2014). Methods used to validate measures usually involve 
assessments of validity and reliability. Validation studies provide guidance in terms of 
accurate and efficient methods for screening and assessment in research and clinical practice 
(Meader et al., 2014; Prisnie et al., 2016).  
Evidence from the systematic review suggests that research and clinical practice does 
not often include any multidimensional assessment of apathy. Emotional, behavioural and 
cognitive domains of apathy have distinct neurocognitive correlates which could be 
overlooked when treating apathy as a unitary syndrome (Njomboro & Deb, 2014). Being 
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more specific about the nature of apathy will enable the development of more specific 
rehabilitation approaches to optimise functional outcomes.  
A standard for the diagnosis of apathy is still needed (Van Reekum et al., 2005). If 
clinicians and researches choose to move to a more fine-grained, multidimensional 
assessment of PSAp, they would face the issue that there are no such measures validated for 
stroke. A validation study of the DAS in stroke populations is therefore considered to be of 
high clinical relevance, and subsequently the objective of the following empirical paper. The 
DAS is available in Appendix I.  
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Abstract 
Apathy, a disorder of motivation observed in up to 40% of stroke survivors, is negatively 
associated with stroke rehabilitation outcomes. Different apathy subtypes have been identified 
in other conditions, but there is currently no validated multidimensional measure of post-
stroke apathy (PSAp). The Dimensional Apathy Scale (DAS) assesses apathy across three 
subtypes: Executive, Emotional and Initiation apathy (Radakovic & Abrahams, 2014). We 
aimed to test if the DAS is a valid and reliable tool to detect and characterise apathy in stroke. 
Fifty-three stroke survivors, (45.3% males, median age 54), and 71 in the non-stroke group 
(26.8% males, median age 45) completed measures of apathy (DAS, Apathy Evaluation 
Scale, AES), depression (Patient Hospital Questionnaire, PHQ-9) and anxiety (Generalised 
Anxiety Disorder scale, GAD-7) as part of an online survey. The DAS showed high internal 
consistency and convergent validity with the current gold standard unidimensional assessment 
for apathy (AES) and divergent validity with depression (PHQ-9) and anxiety (GAD-7). 
Stroke survivors scored significantly higher on the total score of DAS and all subscales, 
compared with controls. Stroke survivors scored significantly higher for depression, but not 
anxiety. Our results suggest the DAS is a valid and reliable screening tool to detect and 
characterise PSAp.  
Keywords: apathy, stroke, Dimensional Apathy Scale, validity, reliability, depression 
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Apathy affects many stroke survivors and threatens to limit their recovery following 
stroke (Mayo, Fellows, Scott, Cameron, & Wood-Dauphinee, 2009;  Mikami, Jorge, Moser, 
Jang, & Robinson, 2013).. Apathy is a disorder of diminished motivation, associated with a 
marked reduction of initiative, social interactions, activities, cognitive processes and 
emotional responsivity (Cummings et al., 1994;  (Marin, Biedrzycki, & Firinciogullari, 1991; 
Robert et al., 2002). It is prevalent after stroke, affecting 22 – 41% of stroke survivors 
(Caeiro, et al., 2013; Matsuzaki et al., 2015; Van Dalen, Van Charante, Nederkoorn, Van 
Gool, & Richard, 2013). Post-stroke apathy (PSAp) has a negative impact on recovery (Hama, 
Yamashita, Yamawaki, & Kurisu, 2011; Kennedy, Granato, & Goldfine, 2015). It is 
associated with greater physical disability and impaired cognitive functioning and often 
associated with greater long-term impairment (Hama et al., 2007; Harris, Elder, Schiff, 
Victor, & Goldfine, 2014; Tang et al., 2015).  
PSAp has important clinical implications, but is relatively under-researched (Brodaty 
et al., 2013). There are currently no recommendations or mention of PSAp in NICE guidance 
in the UK (NICE, 2019). Despite this, however, it is important to detect, and address PSAp 
given its association with stroke rehabilitation outcomes (Harris et al., 2014; Tang et al., 
2015).  
There are reported to be distinct subtypes of apathy affecting initiation, executive 
functioning and emotional neutrality (Le Heron, Apps, & Husain, 2017; Levy, 2012). Several 
apathy scales, such as the Apathy Scale (Starkstein, Mayberg, Andrezejewski, Leiguarda, & 
Robinson, 1992) and the Apathy Evaluation Scale (Marin et al., 1991) have in common, 
however, that they provide only a unidimensional score of apathy severity, on the assumption 
that apathy is a unidimensional phenomenon. 
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Based on the  model of Levy and Dubois (2006) the Dimensional Apathy Scale (DAS, 
Radakovic & Abrahams, 2014) assesses three subtypes of apathy. The DAS consists of three 
subscales: Executive Apathy, or the lack of motivation for planning, organisation or attention: 
Emotional Apathy, or emotional indifference and neutrality; and Initiation Apathy, or the lack 
of motivation for self-generation of thoughts or actions (Radakovic & Abrahams, 2014). The 
DAS has been validated in Motor Neurone Disease (Radakovic et al., 2016), Parkinson’s 
disease (Radakovic, Davenport, Starr, & Abrahams, 2018) and dementia (Radakovic & 
Abrahams, 2014). These validation studies have found positive intra-correlations between 
DAS subtypes. It is not yet, however, validated for acquired brain injuries, such as stroke.  
Given the high prevalence and clinical importance of PSAp (Hama et al., 2011; Van 
Dalen et al., 2013; Withall, Brodaty, Altendorf, & Sachdev, 2009), we aimed to investigate 
the psychometric properties and validity of the DAS against a ‘gold-standard’ unidimensional 
measure of apathy and to assess its associations with depression and anxiety in stroke 
survivors and a non-stroke group. Based on the above literature, the research questions for 
this study were as follows:   
 
Research question 1: Does the Dimensional Apathy Scale show adequate validity and internal 
consistency in stroke? 
• Hypothesis 1a: It is hypothesized that the DAS will show adequate internal 
consistency when completed by stroke survivors and the DAS subscales will be 
positively inter-correlated with each other, as found in previous validation studies in 
other conditions (Radakovic & Abrahams, 2018; Radakovic, Starr, et al., 2017; 
Radakovic et al., 2016; Radakovic, Stephenson, et al., 2017). 
• Hypothesis 1b: In line with previous research, (e.g. Radakovic et al., 2016) it is 
hypothesized that there will be a positive correlation, or convergent validity, between 
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DAS and AES total scores, as both are measures of apathy. It is also hypothesized that 
the emotional aspects of PHQ-9 and GAD-7 for depression and anxiety will be 
negatively correlated with apathy, and therefore show divergent validity for DAS. 
Research question 2: How do the DAS profiles differ between stroke survivors and non-stroke 
survivor groups? 
• Hypothesis 2: It is hypothesized that the stroke survivor group will have a higher 
prevalence of all three dimensions of apathy compared with the control group.   
 
Method 
Design 
This is a cross-sectional observational study, with a 2x3 mixed factorial design (e.g. a 
two-level between participants factor of group and a three-level within participants factor of 
DAS subscale). The chosen design is in line with the design used in previous studies 
validating the DAS in other neurological disorders, allowing validation and comparison of 
profiles (Radakovic & Abrahams, 2018; Radakovic, Starr, et al., 2017; Radakovic et al., 2016; 
Radakovic, Stephenson, et al., 2017). 
Participants 
Our primary focus was on adult stroke survivors. The inclusion criteria for our stroke 
survivor group were: being 18 years or older and having experienced a stroke that required 
hospital attendance at age 18 or above. The inclusion criteria for the non-stroke survivor 
group were: being 18 years and older. The exclusion criteria for the stroke group were major 
medical, neurological, or psychiatric co-morbidities unrelated to stroke (e.g. neither a 
potential risk factor nor consequence of stroke). The exclusion criteria for the non-stroke 
group were major medical, neurological, or psychiatric conditions. These exclusion criteria 
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were applied to allow the study to focus on apathy caused by stroke rather than other 
conditions.  
We included participants with anxiety and depression, as these are frequent 
consequences of stroke and we aimed to recruit a representative sample of stroke survivors. 
Depression and anxiety were screened using the GAD-7 and PHQ-9 in the questionnaires to 
enable us to characterise the divergent validity of the DAS in relation to other disorders. 
Procedure  
Stroke survivors and non-stroke participants were recruited to an online survey via 
Twitter and Facebook. Stroke charities (e.g. Headway, Stroke Association UK, Stroke 
Association NI) were contacted to increase visibility of the study. Bristol online surveys was 
used to collect data. All participants were given an option to enter a prize draw of five £25 
Amazon vouchers. This study was granted ethical approval from the University of East 
Anglia Faculty of Medicine and Health Sciences Research Ethics Committee and followed the 
General Data Protection Regulation (GDPR) guidelines (Information Commissioner’s Office, 
2018). Participants gave informed consent in line with the Declaration of Helsinki (World 
Medical Association, 2013).  
The research team, consisting of people with expertise in stroke psychology and 
apathy research, independently reviewed whether participants met inclusion or exclusion 
criteria, based on the information provided about their health in the survey. This was followed 
by a discussion to reach consensus where there were inconsistencies. Participants were 
excluded on the basis of declaring a health condition unrelated to stroke but with a known 
association with apathy, to ensure that the current study measured apathy due to stroke rather 
than due to another condition. A few examples of medical conditions forming the basis of 
exclusion from both groups were: idiopathic intracranial hypertension, traumatic brain injury, 
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congenital cervical stenosis, epilepsy, spina bifida, ongoing cancer, bipolar 1 disorder, and 
ongoing substance abuse.  
Measures 
 Demographic and clinical data on age, gender, years of education, occupation, marital 
status, age when admitted to hospital for stroke and other mental or physical health conditions 
were collected at the beginning of the survey.  
Apathy  
 The Dimensional Apathy Scale (DAS, Radakovic & Abrahams, 2014) is a 24-item, 
three-dimensional scale for assessment of apathy subtypes. It has three subscales, each with 8 
items. All items are rated on a 4-point Likert-scale, ranging from 0 (Almost always) to 3 
(Hardly ever). Overall scores range from 0-72, higher scores indicate more apathy. Cut-off 
scores for abnormal scores are: Total ≥ 39, Executive subtype ≥ 14, Emotional subtype ≥ 15 
and Initiation subtype ≥ 16 (Radakovic & Abrahams, 2014). The measure was found to have 
acceptable internal consistency for Parkinson’s disease (Cronbach’s α=.84, Radakovic et al., 
2018), Alzheimer’s disease (α=.85, Radakovic, Starr, & Abrahams, 2017) and ALS (α=.86, 
Radakovic, Stephenson, et al., 2017). Informant/carer-rated and self-versions are available. 
The self-rated version was used.  
 The Apathy Evaluation Scale (AES, Marin et al., 1991) comprises of 18 items 
measuring general apathy. Each item is rated on a 4-point Likert-scale, ranging from 1 (Not at 
all) to 4 (A lot). The scale has good internal consistency (α=.86-94), and test-retest reliability 
(α=.76-94), (Marin et al., 1991). There are three versions of this scale, for clinicians, 
informants and self-rated versions. The version used in this study was the self-rated version. 
Scores range from 18 to 72, higher scores indicate abnormal levels of apathy.  
Depression 
 The Patient Health Questionnaire (PHQ-9, Kroenke, Spitzer, & Williams, 2001) is a 
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screening tool for depression, based on the DSM-IV criteria., validated for post-stroke 
depression (Prisnie et al., 2016). Each item is rated on a 4-point Likert-scale, ranging from 0 
(Not at all) to 3 (Nearly every day). Distribution of scores in terms of depression severity is as 
follows: minimal = 0-4, mild = 5-9, moderate = 10-14, moderately severe = 15-19 and severe 
= 20-27 (Kroenke et al., 2001). PHQ-9 has excellent internal validity (α=.89) and test-retest 
reliability (Kroenke et al., 2001). Individuals scoring 10 or higher on the scale have a 88% 
chance of meeting diagnostic criteria for depression (Kroenke et al., 2001).  
Anxiety 
 The Generalised Anxiety Disorder (GAD-7, Spitzer, Kroenke, Williams, & Löwe, 
2006) is a 7-item screening tool for anxiety, based on the DSM-IV criteria, validated for 
stroke. GAD-7 has excellent internal validity (α=.92), with good test-retest reliability 
(intraclass correlation coefficient =.82) (Spitzer et al., 2006). Each item is rated on a 4-point 
Likert-scale, ranging from 0 (Not at all) to 3 (Nearly every day).  The distribution of GAD-7 
scores in terms of level of anxiety severity is as follows: minimal = 0-4, mild = 5-9, moderate 
= 10-14 and severe = 15-21 (Spitzer et al., 2006).  
Statistical Analysis 
To explore how all variables of interest is associated with each other across all 
conditions, G*Power 3.1.9.4 (Faul, 2007), was used to calculate required sample size for the 
mixed design ANOVA. A medium effect size is considered a conventional estimate, which 
yielded an estimated sample size of 44 participants. The power calculation is available in 
Appendix D.  
IBM SPSS v.25 was used for data analysis. The analysis plan included checking for 
missing data and and replacing missing values using median imputation, and to assess 
distributions across variables. Parametric or non-parametric tests were planned as appropriate 
to test internal consistency and the associations between measures in the stroke group to 
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validate the measure, to test effects of group, subscale and interaction between them to 
characterise apathy in the two groups and then give the details of tests in the results.  
 
Results 
Characteristics 
One-hundred-and-forty people completed the online questionnaire. Altogether 53 
stroke survivors and 71 people who have not experienced stroke were included in the analysis. 
Seven stroke survivors and nine people who have not experienced stroke were excluded from 
further analysis on medical, psychiatric and neurological grounds. Only 43% of stroke 
survivors and 81% of the participants without stroke completed the questionnaire. As seen in 
Table 1, the two groups were matched on gender, living arrangements, and years of education, 
but differed significantly on age and occupational status.  
Table 1 
Demographic Characteristics for Stroke Survivors (N=53) and the Non-stroke Group 
(N=71) 
 
Factor Stroke survivors Non-stroke group U  χ2 df p 
Age, Median (IQR) 54 (14) 45 (27) 1327.5     .005 
Gender male (N %) 24 (45.3) 19 (26.8)   5.13 2 .077 
In employment or studies N (%) 23 (43.4) 63 (88.7)   35.67 1 .001 
Living arrangement, N (%)       2.06 6 .915 
  Single 12 (22.6) 18 (25.4)   122 1 .727 
  Married/ partnership 37 (68.7) 36 (50.7)   136 1 .712 
  Divorced/ separated 3 (5.7) 4 (5.6)   123 1 .726 
  Other 1 (1.9) 2 (2.8)   .04 1 .834 
Years of education, Median 
(IQR) 13 (3) 13 (2) 2077.0     .230 
Having a University degree, N 
(%) 31 (58.5)  52 (73.2)    3.51 1 0.61 
IQR= Interquartile Range, significant findings are indicated in bold.   
As seen in Table 2 ischemic strokes were the most common stroke type. Strokes in left 
and right hemispheres were almost equally represented, but 43% of stroke survivors did not 
specify stroke-location. Relatively few stroke survivors had experienced repeated strokes.  
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In our stroke group there where were no significant correlations (Spearman's Rho) 
between age and apathy on the DAS (DAS total score, rs(51) = .138, p =.328; DAS Executive 
Apathy, rs (51)=-.222, p=.110; DAS Initiation Apathy, rs (51)=-.212, p=.127); and DAS 
Emotional Apathy, rs (5)1=.156, p=.263). The correlation between age and the DAS total 
score control group was non-significant rs(69)=-.166, p=.127).  
Table 2  
Clinical Characteristics for Stroke Survivor Participants (N = 53). 
Clinical Characteristics  
Age at first hospital admission, mean (SD) 47.50 (12.7) 
Types of strokes N (%)   
  Ischemic  28 (52.8) 
  Haemorrhagic 19 (35.9) 
  Type of stroke not specified 6 (11.3) 
Stroke location N (%)   
  Right hemisphere 15 (28.3) 
  Left hemisphere 14 (26.4) 
 Hemisphere not specified 24 (45.3) 
  Frontal lobe 4 (7.6) 
  Parietal lobe 2 (3.8) 
  Temporal lobe 2 (3.8) 
  Occipital lobe 0 (0.0) 
  Cerebellar 3 (5.7) 
  Subcortical (e.g. basal ganglia, thalamic) 6 (11.3) 
  Mixed locations   4 (7.6) 
  Stroke location not specified   32 (60.4) 
Multiple strokes, N (%) 6 (10.0) 
  Average number of multiple strokes, mean (SD) 2.6 (55) 
SD= standard deviations 
 
Data Preparation 
Missing data were handled using median imputation (Acuña & Rodriguez, 2004; 
Tabachnick & Fidell, 2013). Where possible non-parametric tests were used. A 2x3 mixed 
ANOVA with a Greenhouse Gleiser correction testing differences between groups and 
subscales on the DAS and the interaction between these factors, see details in Chapter 5. 
 
POST-STROKE APATHY   91 
 
Psychometric Properties of DAS in Stroke 
Internal Consistency of the DAS  
Overall, the DAS had a good level of internal consistency for stroke survivors (α=.84) 
and an acceptable level for people who have not experienced stroke (α=.76). Internal 
consistency was acceptable for the initiation apathy (α=0.79) and executive apathy subscales 
(α=0.74), but questionable for the emotional subscale (α=0.64) for the stroke group.  
Convergent Validity of the DAS 
As seen in Table 3, the DAS total scores had a strong, positive correlation with the 
AES. The Initiation and Executive Apathy subscales were also strongly positively correlated 
with the AES and the emotional subscale showed a moderate positive correlation with the 
AES. These findings support the convergent validity of the DAS in stroke. 
 For the stroke group the DAS total score correlated significantly with all subscales: 
Emotional Apathy rs(51)=.71, p<.001, Executive Apathy rs(51)=.85, p<.001, and Initiation 
Apathy r(51)=.86, p<.001. Significant positive intercorrelations were also found between all 
DAS subscales: Emotional Apathy vs Initiation Apathy rs(51)=.39, p<.01, Emotional Apathy 
vs. Executive Apathy rs(51)=.38, p<.01, and Executive Apathy vs initiation Apathy 
rs(51)=.67, p<.001.  
Divergent Validity of the DAS 
Correlations between the DAS, AES, PHQ-9 and GAD-7 are presented in Table 3. The 
relationship between the DAS Emotional Apathy subscale and GAD-7 was non-significant, as 
was the relationship between the DAS Emotional Apathy subscale and PHQ-9. As emotional 
apathy, depression and anxiety are considered different constructs, this supports the divergent 
validity of the DAS in stroke.  
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Table 3 
Correlations between DAS, AES, PHQ-9 and GAD-7 for Stroke Survivors (N = 53. 
Stroke survivors (N=53) AES PHQ-9 GAD-7 
  DAS Executive subscale .775** .620** .427** 
  DAS Emotional subscale .523** .030 -.031 
  DAS Initiation subscale .756** .510** .288* 
**p<.001, *p<.05.  
AES (Apathy Evaluation Scale), PHQ-9 (Patient health Questionnaire), GAD-7 
(Generalised Anxiety Disorder-7)  
 
Group Comparisons across measures 
Mann-Whitney U tests were run to determine if there were group differences across 
questionnaires. Distributions of scores for the stroke- and non-stroke group were similar, as 
assessed by visual inspection (presented in Table 4). Groups differed on all scales, except for 
the GAD-7. 
Table 4 
Mann-Whitney U tests of Group Differences in DAS, AES, PHQ-9 and GAD-7 scores, with 
Bonferroni correction.  
Scale Stroke median (IQR) 
None-stroke median 
(IQR) U p 
DAS total 34 (18) 24 (29) 934.00 <.001 
DAS Executive 
Apathy 
12 (8) 8 (6) 1152.00 <.001 
DAS Emotional 
Apathy 
12 (8) 9 (4) 1165.00 <.001 
DAS Initiation 
Apathy 
10 (6) 6 (5) 995.00 <.001 
AES 34 (17) 28 (8) 1197.50 <.001 
PHQ-9 8 (9) 3 (4) 1641.50 .018 
GAD-7 5 (6) 3 (6) 1801.00 .409 
IQR = Interquartile range, p-values in bold show significant differences. 
 
Group Comparison on the DAS 
Scores on the DAS showed a significant main effect of group (F(1,22)=33.17, 
p<.001). As seen in Figure 1, the DAS scores of stroke survivors were higher than those of the 
non-stroke comparison group. There was also a significant main effect of DAS subscale 
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(F(2,228) =14.82, p<.001). The interaction between group and subscale was not significant 
(F(2,228)=.25, p=0.764), indicating that there was no significant difference in the profile of 
subscales between the two groups. Figure 1 shows the means for each group across subscales. 
 
Figure 1 
 DAS Apathy profiles for the Stroke and Non-stroke Groups: Means and Standard Errors  
 
 
Non-parametric tests confirmed the significant main effects of groups and subscale. 
The results of Mann-Whitney U group comparisons per scale and subscale are presented in 
Table 4. A non-parametric Friedman’s test found significant effect of subscale (χ2(3)=103.06, 
p<.001,W=.65), as well as significant pairwise comparison between the subscales for the non-
stroke group (χ2(3)=141.80, p<.001, W=.67).  
Group Comparison of Caseness  
As seen in Figure 1, the DAS profiles of both groups followed similar patterns, 
although stroke survivors had higher levels of apathy across all apathy subtypes. Table 5 
presents cut-off scores for the DAS in stroke, calculated as two standard deviations above our 
11.2
12.1
10.2
8,3
9.1
6.8
0,0
2,0
4,0
6,0
8,0
10,0
12,0
14,0
Executive subscale Emotional subscale Initiation subscale
S
co
re
DAS subscale
Stroke
Control
POST-STROKE APATHY   94 
 
non-stroke group means. The non-stroke group was matched to our stroke sample, with no 
significant differences in gender, age (U=1480.5, p=.511) or years of education (U=1185.0, 
p=.209) between groups.  
As seen in Table 5, these calculated cut-off scores are similar to published cut-offs 
(Radakovic et al., 2016). We judged that published cut-off scores could therefore be applied 
to our stroke sample and used these to determine caseness.  
Table 5 
Calculation of DAS cut-off scores, based on our matched non-stroke group, and published 
cut-off scores.  
DAS   Mean (SD) Cut-off Radakovic et al., (2016) Cut-off 
Executive subscale 7.94 (3.49) 15 14 
Initiation Subscale 8.96 (3.66) 16 16 
Emotional subscale  7.08 (3.28) 14 15 
Total score  23.98 (7.40) 39 39 
 
 
As seen in Table 6, there were significant differences of caseness between groups 
across all measures, except for the GAD-7. Cut-offs were based on the published scores. In 
addition to apathy, there were significantly more stroke survivors scoring above the cut-off 
for depression compared with the non-stroke group.  
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Table 6 
Frequencies of participants meeting the diagnostic cut-offs for the assessment tools. P values 
are corrected for multiple comparisons using Bonferroni correction.  
 Scale Stroke N (%) Non-stroke N (%) χ2 p 
DAS total 17 (32.1) 3 (4.2) 17.40 <.001 
DAS Executive apathy 18 (34.0) 7 (9.9) 10.95 .002 
DAS Emotional subscale 9 (17.0) 0 (0) 13.00 .001 
DAS Initiation subscale 14 (26.4) 3 (4.2) 12.63 .001 
AES 23 (43.4) 5 (7.0) 22.94 <.001 
PHQ-9 9 (17.0) 3 (4.2) 5.65 .038 
GAD-7 6 (11.3) 5 (7.0) .69 .610 
DAS= The Dimensional Apathy Scale (Radakovic et al., 2016). DAS total cut-off score  ≥39, DAS 
Executive apathy cut-off score ≥14, DAS Emotional subscale cut-off score ≥15,DAS Initiation subscale 
cut-off score ≥6. AES= The Apathy Evaluation Scale (Marin et al., 1991), cut-off score ≥37. PHQ-9= 
The Patient Health Questionnaire (PHQ-9, Kroenke, Spitzer, & Williams, 2001), cut-off  score ≥15. 
GAD-7 = The Generalised Anxiety Disorder (GAD-7, Spitzer, Kroenke, Williams, & Löwe, 2006), cut-
off score ≥10. p-values in bold show significant differences.  
 
Forty-three percent of stroke survivors scored above cut-off on multiple apathy 
subtypes on the DAS. As seen in Table 7, these stroke survivors also had significantly higher 
scores for depression (PHQ-9) and anxiety (GAD-7), than stroke survivors who did not score 
above apathy cut-offs. The median number of apathy subtypes was two. Eight stroke survivors 
(15.1%) scored above cut-off for one subscale, eight (15.1%) scored above cut-off on two 
different subscales and six (11.3%) had elevated scores on all three subscales.  
Table 7 
Comparison of Stroke Survivors According to Number of Apathy Subtypes with Bonferroni 
correction.  
  
Above Published Cut-
offs for ≥ 1 Apathy 
Subtype (N = 23) 
Below Published 
Cut-offs for Apathy 
Subtypes (N = 30) p 
Age, median (IQR) 54.0 (17) 54.0 (11) .986 
Years of education, median 
(IQR)  
12.0 (2) 13.0 (2) .167 
Multiple strokes median (IQR) 0.0 (0) 0.0 (0) .767 
Age at first stroke, median (IQR) 46.5 (13) 49.0 (10) .785 
PHQ-9, median (IQR) 11.5 (10) 5.0 (8) <.001 
GAD-7, median (IQR) 7.0 (13) 4.0 (5) .015 
IQR= interquartile range, p-values in bold show significant differences. 
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Discussion 
We aimed to investigate if the DAS is a valid and reliable screening tool for apathy in 
stroke survivors. The DAS has been validated for degenerative diseases, but not for stroke 
(Radakovic & Abrahams, 2018; Radakovic, Starr, et al., 2017; Radakovic et al., 2016; 
Radakovic, Stephenson, et al., 2017). We found that the DAS showed good internal 
consistency and was strongly correlated with the AES, indicating good convergent validity. 
The DAS also showed good divergent validity in stroke, with significant positive correlations 
between Executive and Initiation apathy and depression but not Emotional apathy and 
depression, consistent with the distinction drawn between depression and emotional neutrality 
as an apathy subtype.   
Stroke survivors showed higher levels of apathy on the DAS, than did the non-stroke 
comparison group, for each of the three apathy subtypes in terms of symptom-rating and for 
caseness. Forty-three percent of stroke survivors displayed one or more apathy subtype, with 
the most common subtypes being Initiation and Executive apathy. The Emotional subtype was 
less common and reliable, and findings should be interpreted with caution. Low reporting on 
emotional apathy has been considered a possible indication of dysfunction in social cognition, 
and self-awareness (Radakovic et al., 2018; Radakovic, Starr, et al., 2017).  
The DAS apathy profiles for stroke survivors and people who have not experienced 
stroke followed similar patterns. Our stroke sample showed a similar profile of apathy 
subtypes to profiles reported for people with Parkinson’s (Radakovic et al., 2018) and 
Alzheimer’s disease (Radakovic, Starr, et al., 2017). In Alzheimer’s disease, no associations 
between the Emotional apathy subscale and depression were found, arguing that people with 
Alzheimer’s have an awareness deficit in terms of Emotional apathy and depression 
(Radakovic, Starr, et al., 2017). Although no correlations were found between Emotional 
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apathy and depression in our sample, stroke survivors did report higher levels of both, 
compared with the non-stroke group. 
Our findings show the importance of screening for both apathy and depression in 
clinical settings. Stroke survivors with more than one apathy subtype have significantly higher 
depression scores. This might indicate that it is useful to take apathy into account when 
treating depression and vice versa. Stroke survivors showed significantly higher levels of 
depression than the non-stroke group, but the prevalence of depression was still relatively low 
for this sample. This might possibly be associated with the relatively high level of motivation 
needed to complete the survey, as severe depression would similarly to severe apathy make 
the completion of the survey more challenging. Seventeen percent of our stroke survivors 
scored in the moderately severe to severe range for depression, which is lower than the 
estimated 30 % prevalence of post-stroke depression (Barker-Collo, 2007; Das & Rajanikant, 
2018).  
Apathy research has found associations between older age and more severe apathy 
scores (Brodaty, Altendorf, Withall, & Sachdev, 2010; Sagen, et al., 2010; Starkstein, Ingram, 
Garau & Mizrahi, 2005). For example, a longitudinal study found that apathy scores were 
more pronounced in heathy participants after the age of 65 years (Brodaty, et al., 2010). It was 
therefore potentially problematic that our groups were not matched for age. However, both the 
stroke sample and the control group were younger than participants in studies reporting an 
association between apathy and age (with a median age of 54 for stroke survivors and 45 
years for controls) and showed no association between age and apathy. 
There were also no significant associations between apathy and years of education, 
age of stroke onset, or gender. We did not include comparison based on type of stroke or 
stroke location, due to sample size.  
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Strengths, limitations and recommendations 
This is the first validation of a multidimensional apathy scale in stroke. Despite being 
theorised to be multidimensional, research has frequently used unidimensional apathy scales 
such as the AES (Marin et al., 1991) and AS (Robert et al., 2002). We argue that the 
validation of the DAS in stroke survivor groups is a valuable contribution to PSAp research, 
as this scale reflects the current multidimensional conceptualisation of apathy.  
A challenge faced in all apathy research is sampling the full range of apathy, as 
research is often based on self-selected samples. Nevertheless, we found higher levels of 
apathy in our stroke sample compared to our non-stroke group. It is possible however, that 
PSAp is even more prevalent than found in this study, given the levels of motivation required 
to access and complete an online survey. The dropout rate was nearly twice as high in the 
stroke survivor group, where over half of the participants discontinued the survey before 
completion. We speculate that some of these participants dropped out due to lack of 
motivation and this might indicate even higher prevalence of apathy for stroke than captured 
by our survey. The high prevalence of PSAp and implications for functional activity and 
recovery highlights the importance of this area of research (Hama et al., 2011; Harris et al., 
2014). We were not able to obtain detailed, verified clinical information about participants in 
this study. Future research could usefully test associations between clinical variables 
(including type of stroke, stroke location and premorbid functioning) and apathy profiles by 
recruiting from clinical services.  
Apathy research is still in its infancy and there is a need for more investigation of the 
assessment and treatment of apathy after stroke. We recommend validation of the carer-
version of the DAS, as well as the Brief DAS, for rapid detection of apathy in the clinic 
(Radakovic et al., 2019). The emotional apathy subscale needs further research, perhaps this is 
easier assessed using informant rating. DAS also has clinical implications, as someone with 
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initiation apathy might need different support from others with executive apathy. Apathy is 
often considered secondary to other neurological or psychiatric difficulties after stroke and 
frequently underdiagnosed (Chase, 2011). We therefore welcome and encourage research 
investigating treatment options for the different DAS apathy profiles.    
Conclusions 
 Given the high prevalence of PSAp and its implications for rehabilitation, the present 
study aimed to validate a multidimensional screening tool for apathy. This is important as no 
multidimensional measures have previously been validated for stroke. We found that DAS is 
a psychometrically robust method assessing multidimensional apathy in stroke and 
recommend using published DAS cut-off scores. Stroke survivors scored significantly higher 
on the Executive, Initiation and Emotional subscales of the DAS compared with the non-
stroke group. Forty-three percent of stroke survivors scored above the cut-off for apathy on 
one of the subscales, and 63.6% of these scored above cut-off for multiple subscales. Clinical 
implications of these findings are that there is a need of modification in current practice in 
terms of assessment and interventions for PSD, PSA and PSAp. 
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Additional Methodology and Results 
The empirical study was granted ethical approval from the Faculty of Medicine and 
Health Sciences Research Ethics Committee FMH-REC at the University of East Anglia 
(reference number:  201819 – 026) and followed the Health and Care Professions Council 
(HCPC, 2016), British Psychological Society (BPS, 2018) and UEA Codes of Conduct (UEA, 
2018). 
As seen in Appendix P-U changes were made to the analysis plan to ensure the 
protection and integrity of anonymity using online methods for data-collection. These changes 
limited the time for data collection. 
It is also worth mentioning that the use of online surveys is a relatively novel form of 
data collection in stroke. We were only able to identify a few studies using this sampling 
method e.g. (Rankin, Tran, Rankin, & Lees, 2014; Stein, Hillinger, Clancy, & Bishop, 2013) 
– we were not able to identify any validation studies using this method.  
In terms of data preparation, missing data appeared to be at random counting for 
0.81% on two DAS items. Two participants from the stroke group missed one question each 
from the DAS. In these cases, recommendations to use median imputation were followed  
(Acuña & Rodriguez, 2004; Tabachnick & Fidell, 2013).  
Sampling distribution was visually checked using frequency graphs and Shapiro-Wilk 
tests used to investigate normality and linearity. Assumptions of normality were not met. 
Shapiro-Wilk tests showed significant departures from normality (W(124) = .97, p < .01) for 
the DAS total score, DAS executive apathy subscale (W(124) = .97, p < .01), and DAS 
emotional apathy subscale (W(124) = .98, p < .05) which were all positively skewed. Where 
possible non-parametric tests were used, with the exception of  a 2x3 mixed measure analysis 
of variance (ANOVA) with a Greenhouse Gleiser correction was used testing differences 
between groups and subscales on the DAS and the interaction between these factors, since 
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ANOVA is considered robust even when assumptions of normality and equal variances are 
not met (Blanca, Alarcón, Arnau, Bono, & Bendayan, 2017). 
In the empirical paper a 2x3 mixed model analysis of variance (ANOVA) was used to 
perform a between-group comparison of scores from stroke and non-stroke groups and a 
within-group comparison of scores on the three Dimensional Apathy Scale subscales (DAS, 
Radakovic & Abrahams, 2014). Mixed model analysis of variance has four main assumptions: 
(1) the assumption of normality, or that scores in each condition are sampled from a normally 
distributed population; (2) the assumption of homogeneity of variance, or that variances are 
the same across conditions; (3) the assumption of independence, or that samples are 
independent and selected at random; and (4) the assumption of sphericity, or that variances of 
the differences between within-subject conditions are equal (Field, 2013). 
In our sample the assumption of normality was not met for the DAS total score or 
DAS subscales, as the distribution of these scores were significantly different to the normal 
distribution. All scores were positively skewed. A Shapiro-Wilk test was significant for the 
DAS total score (W(124) =947, p <.001), for the executive subscale (W(124) =957, p =.001), 
the initiation subscale (W(124) =973, p =.013), and the emotional subscale (W(124) =976, p 
=.025). This is however a greater problem for very small datasets (Field, 2013).  
The data also violated the sphericity assumption, as the variance of all differences 
between all pairs in the ANOVA were significantly different. When the assumption of 
sphericity is not met, there is a risk that the findings on the F test are too liberal, finding 
significant differences where there are none (Haverkamp & Beauducel, 2017). The 
Greenhouse-Geiser correction is used to estimate the covariate matrix and is considered a 
robust correction when the assumption of sphericity is violated (Abdi, 2010). The ANOVA is 
considered robust, even when assumptions are violated, given that the sample size is over 30 
(Haverkamp & Beauducel, 2017).  
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There is no single non-parametric equivalent of a mixed model ANOVA. To carry out 
the same comparisons using non-parametric tests would have required multiple Mann-
Whitney U tests of between group differences and Friedman tests of within group differences. 
When performing repeated comparisons without correction there is a risk of a Type 1 error, or 
the rejection of a true null hypothesis, ‘known as a false positive’ (Field, 2013). The decision 
was to run the 2x3 ANOVA for the empirical paper, given the robustness of this method with 
larger sample sizes.  
As seen in Table 4 in chapter 4, we calculated scores for the Apathy Evaluation Scale 
(Marin, Biedrzycki, & Firinciogullari, 1991).On the AES, 43.4% of the stroke survivors fell 
above the published cut-off for apathy (≧38), this was only 5.6% for the non-stroke group. 
Depression rates as measured by the PHQ-9 were lower, 17% of stroke survivors scored 
above the moderately severe cut-off. In the non-stroke group, 4.2% scored above this cut-off. 
Anxiety scores were higher, with 11.3% of the stroke sample scoring in the severe range 
(18.9% in the moderate range), and 5.6% of the people who have not experienced stroke 
(11.3% in the moderate range). The AES was found to have a strong positive correlation with 
the PHQ-9 in the stroke group rs(51) = .71, p < .001 and a moderate correlation in the non-
stroke group rs(68) = .44, p < .001.  
Lastly, our stroke and non-stroke samples were matched by ranking participants in the 
control group based on age (taking gender and years of education into account, to ensure 
samples still matched on these factors). Participants at the lower end were excluded from the 
non-stroke condition, leaving both groups with 53 participants.  
In the empirical paper, we judged that published cut-off scores could therefore be 
applied to our stroke sample and used these to determine caseness. We did however calculate 
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the cut-off scores again, using cut-offs from our own sample. Findings are presented in Table 
1.  
Table 1 
Frequencies of participants meeting the diagnostic cut-offs for the DAS, using our own cut-off 
scores, comparing stroke group with our matched non-stroke survivors. P values are 
corrected for multiple comparisons using Bonferroni correction.  
 Scale Stroke N (%) Non-stroke N (%) χ2 p 
DAS total 17 (32.1) 3 (4.2) 17.40 <.001 
DAS Executive apathy 15 (28.3) 3 (5.6) 9.38 .002 
DAS Emotional subscale 9 (17.0) 0 (0) 9.56 .002 
DAS Initiation subscale 19 (35.85) 6 (11.32) 8.55 .003 
DAS= The Dimensional Apathy Scale (Radakovic et al., 2014). DAS total cut-off score  ≥39, DAS 
Executive apathy cut-off score ≥15, DAS Emotional subscale cut-off score ≥14, DAS Initiation subscale 
cut-off score ≥16.  
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Discussion 
Thesis Aims  
The overall aims of this thesis were to examine the impact of apathy on functional 
activity after stroke and to test if the Dimensional Apathy Scale (DAS), a multidimensional 
measure of apathy is reliable and valid  in stroke (Radakovic & Abrahams, 2014). The 
systematic review, or narrative synthesis, focused on the associations between apathy and 
functional activity. It was followed by a validation study, aiming to investigate the 
psychometric properties and validity of the DAS against a gold-standard one dimensional 
measure of apathy, (AES, Marin, Biedrzycki, Ruth, & Firinciogullari, 1991), and its 
associations with depression and anxiety in stroke survivors and a non-stroke comparison 
group 
Integrating findings from different thesis elements 
Given the importance of motivation and the emphasis on goal setting in stroke 
rehabilitation, the systematic review hypothesised that apathy has a negative impact on 
functional outcome after stroke (Chapter 2). Assertiveness and goal directedness are 
associated with patient success in stroke rehabilitation (Dobkin, 2004; Rapolienė et al., 2018) 
whereas lack of motivation has been highlighted as the most important roadblock in 
rehabilitation, with internal and external motivation affecting rehabilitation outcome in stroke 
populations (Rapolienė et al., 2018). Apathy is associated with negative recovery outcomes, 
as well as a negative impact on family life and later social reintegration and autonomy 
following rehabilitation (Arnould, Rochat, Azouvi, & Van Der Linden, 2013).  
The articles reviewed supported the negative impact of apathy on rehabilitation 
outcomes, though there were a few concerns regarding study quality. It was argued that 
although apathy is prevalent following stroke, research on post-stroke apathy is still in its 
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infancy. As highlighted in the systematic review, the lack of validated screening tools is a 
major limitation for PSAp research. All but one of the studies included in the systematic 
review used assessments based on a unidimensional conceptualisation of apathy, therefore 
failing to assess specific apathy subtypes.  
Apathy is now often considered a multidimensional construct (Le Heron, Apps, & 
Husain, 2017; Levy & Dubois, 2006; Marin et al., 1991; Radakovic & Abrahams, 2014) 
distinct from depression (Levy et al., 1998). The only study in the systematic review that used 
a multidimensional measure failed to make use of the potential to characterise subtypes of 
apathy after stroke and examine their functional impact, as it focused on the overall severity 
of apathy (Skidmore et al., 2015).  
Based on the multi-dimensional neurocognitive model of Levy and Dubois (2006), the 
DAS (Radakovic & Abrahams, 2014) is a measure developed to assess three apathy subtypes: 
emotional, initiation, and executive apathy. This provides more detailed data than 
unidimensional measures and should aid formulation and treatment of difficulties. The 
validation of the DAS in stroke was therefore argued to be a valuable contribution to both 
research as well as to clinical practice.  
The findings of Chapter 4 were that stroke survivors scored significantly higher on 
apathy in general, as measured by the DAS and AES, than did controls. Apathy scores were 
high, and consistent with the PSAp research described in the introduction, 43% of stroke 
survivors scoring above cut-off for apathy on the AES in our sample. Just under six percent of 
controls scored above the same cut-off.  
In terms of the dimensions of apathy, stroke survivors had significantly higher scores 
on all dimensions compared with the controls. Initiation and Executive Apathy were 
particularly prevalent in the stroke sample, and these profiles are consistent with the 
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validation studies of Parkinson’s (Radakovic et al., 2018) and Alzheimer’s disease 
(Radakovic, Starr, & Abrahams, 2017).  Self-awareness is closely linked with meta-cognition, 
and the Dimensional Apathy Framework notes that self-awareness subsumes all subtypes of 
apathy, and therefore might be relevant in diseases such as dementia (Radakovic & 
Abrahams, 2018).  
There was a positive correlation between depression and apathy, especially between 
depression on the PHQ-9 and the executive and initiation subtypes on the DAS. More stroke 
survivors scored above cut-off on the DAS and AES, however, compared to the PHQ-9, and 
apathy was found to have a higher prevalence than depression in our sample. The emotional 
subscale on the DAS was not significantly correlated with the GAD-7, which makes sense 
from a theoretical perspective, as people are unlikely to report heightened levels of anxiety at 
the same time as reporting flattened or neutral emotional response. There was no significant 
relationship between the emotional subscale and depression scores on PHQ-9.  
 In line with previous research (Barker-Collo, 2007; Broomfield, Quinn, Abdul-Rahim, 
Walters, & Evans, 2014; Schöttke & Giabbiconi, 2015), stroke survivors had significantly 
higher scores on both depression and anxiety compared with the controls. The effects of 
stroke can have devastating consequences, disrupting functional independence, daily life and 
autonomy (Gençer & Hocaoğlu, 2019; Rapolienė et al., 2018). Anxiety affects about one in 
four stroke survivors and is more frequent in younger survivors (Chun et al., 2018). Phobic 
anxiety is particularly common, and fear of stroke recurrence is the most commonly observed 
stroke related fear (Chun et al., 2018).  
As seen in previous chapters, depression is common after stroke (Towfighi et al., 
2017), and can be understood both as an emotional response to sudden change and disability 
as well as structural changes or biochemical imbalances following changes in the brain after 
stroke (Gençer & Hocaoğlu, 2019). The emotional impact of having a stroke can be linked 
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with mourning and coping with the loss and acceptance of disability, especially when 
individuals refuse to accept their new reality (Hama et al., 2011).  
Apathy seems to be associated with even less favourable rehabilitation outcomes than 
depression (Hama et al., 2007). Therefore, with its devastating impact on stroke rehabilitation 
and outcome, apathy screening should arguably become as routine as depression screening in 
stroke.  
The empirical study showed that the initiation and executive subscales correlated 
positively with depression. Apathy and depression are not the same concept. People might 
struggle to start and finish tasks either because of low mood or apathy. We speculate that not 
being able to carry out goal-directed behaviours in rehabilitation will have implications for the 
person regardless of origin. Further research is needed to investigate the clinical implications 
of this relationship and to investigate if apathy and depression should be screened for in 
combination.  
Apathy can be mistaken for disengagement in rehabilitation, and there is a risk that 
apathy could be confused for lack of rehabilitation goals or wish to carry out rehabilitation 
and patients might not receive the rehabilitation they need and deserve. Patients benefit from 
inpatient stroke rehabilitation, even when experiencing apathy, (Dobkin, 2004; Langhorne, 
Bernhardt, & Kwakkel, 2011; Santa et al., 2008). One of the symptoms of apathy is the lack 
of goal directedness, which makes it harder for this group to identify the needs they have in 
rehabilitation (Langhorne et al., 2011; Mayo et al., 2015, 2009). It must therefore be the 
clinician’s responsibility to identify apathy and to be open minded and flexible in terms of 
treatment options based on the person’s best interests and neurological formulation.  
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Methodological Strengths and Limitations 
We highlight that PSAp is still a novel area of research, in the shadow of post-stroke 
depression. This was the first systematic review directly focusing on the impact of apathy on 
functional recovery, which we consider a strength. The systematic review highlighted the high 
prevalence of PSAp, the negative association with rehabilitation outcomes, as well as the need 
for higher quality research, using validated, multidimensional screening tools. The empirical 
study was the first validation of a multidimensional apathy scale in stroke. We believe that the 
validation of the DAS for stroke population is relevant for use in both clinical and research 
settings, providing a multidimensional alternative to current practices in PSAp research, often 
based on older models of apathy.  
The recruitment of a stroke sample covering the full range of apathy symptoms was 
expected to be challenging, due to the very nature of apathy itself. We did not expect the least 
motivated patients to want to participate in this research study, and this is also a general 
limitation for most apathy research (e.g. Hama et al., 2011; Kennedy, Granato, & Goldfine, 
2015; Matsuzaki et al., 2015). The most severely affected patients will inevitably struggle 
with engagement. This is likely to be a limitation in all apathy research as participants need to 
at least have motivation and capacity to consent to participate. Although expecting that more 
stroke survivors would score in the severe range of apathy, we did however see the full range 
of apathy amongst our respondents.  
We decided to validate the self-rated version of the DAS, as it has shown to be both 
valid and reliable tool for neurodegenerative disorders, which would arguably face the same 
challenges in terms of cognitive impairments (Radakovic, 2016; Radakovic & Abrahams, 
2018; Radakovic, Stephenson, et al., 2017). Especially considering the high prevalence of 
apathy in the other validation studies.  
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The DAS is also recommended as apathy assessment tool in the updated 2018 criteria 
for apathy (Robert et al., 2018). Now we have evidence that the DAS is reliable and valid in 
stroke, research should test the properties of the informant-rated DAS in stroke. The 
informant version could be used even for people with severe apathy or cognitive deficits as it 
does not require abilities across various cognitive domains, including sustained attention, 
executive functioning, working memory, language processing and motor skills to name a few. 
 An unforeseen ethical issue regarding anonymity arose in the first stages of data 
collection for the empirical study. It was possible to identify individual responses and to link 
these with email addresses provided by participants in the online questionnaire. This was 
especially problematic as the PHQ-9 include a suicidality related question, and participants 
were informed the survey was anonymous. This issue was immediately discussed with 
supervisors and brought to the Faculty of Health Sciences and Medicine Research Ethics 
Committee at University of East Anglia (see Appendix P to R). The data collection was 
completely halted until this issue was resolved and amendments approved by the committee, 
resulting in a few changes to the methodological design of the empirical paper. Although 
limiting the time for data collection, the amendments also shortened the questionnaire, 
making it easier to access and complete by participants.  
Another related limitation with the empirical paper concerned the recruitment though 
an online survey. It was positive that we were able to reach stroke survivors to participate in 
the study. Sampling though social media and stroke charities was predicted to allow access to 
a rich community-based sample of stroke survivors. This sampling method did not however 
allow for limitations in terms of who was able to participate. This was especially problematic 
when trying to match the stroke and control group. It was also challenging at times to sustain 
participation rates for the stroke survivor group. Other studies using online sampling methods 
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in stroke have discussed the issues with volunteering bias as well as difficulties gaining access 
too clinical information about participants (Franzén-Dahlin & Laska, 2012; Stein et al., 2013).  
 As data collection was carried out online, without face to face contact, we could not 
clarify by asking follow-up questions regarding lesion location or additional information 
about self-disclosed physical, psychological or neurological illnesses. This could potentially 
have resulted in a few more excluded participants than necessary when evaluating if people 
met inclusion or exclusion criteria. It was also considered an ethical challenge to exclude 
individual participant responses after they had taken the time to complete the survey.  
Clinical implications 
  Findings have clinical implications: they show the need for thorough apathy 
assessment given its prevalence and association with worse rehabilitation outcomes. We hope 
that clinicians will become more aware and that screening for both anxiety and depression 
will become part of everyday practice.  
Future research 
Based on the findings of the systematic review, there is a general need for more high-
quality research on PSAp. As addressed in the empirical study, we would recommend 
validation of the clinician and carer versions of the DAS, as these could allow for more 
objective diagnosis of apathy in stroke. A valuable contribution would also be to elaborate on 
the understanding of neural correlates of apathy subtypes in stroke, looking further into the 
Dimensional Apathy Framework. We hope that future studies will use apathy measures such 
as the DAS instead of unidimensional measures as they provide valuable information to the 
clinician not only on the severity of apathy, but also the profile of apathy. 
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Conclusion 
The systematic review and empirical paper have made a novel contribution to the field 
of apathy research by validating a multi-dimensional measure of apathy which could be used 
to detect and characterise PSAp. We also established that apathy is associated with worse 
functional activity after stroke.  
PSAp research is still in its infancy, and more investigation is needed. Most of the 
research had been conducted around the world, but little research is currently conducted in the 
UK on this topic. Apathy was found to have devastating effects on recovery after stroke, and 
we argued that apathy should be routinely screened for in clinical practice given its 
implication for recovery. The DAS is a valid and reliable screening tool for stroke 
populations, and it is suitable for use in both research and clinical practice. 
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Appendix A: Instructions for authors: The Clinical Neuropsychologist 
COVID-19 impact on peer review  
As a result of the significant disruption that is being caused by the COVID-19 pandemic we understand 
that many authors and peer reviewers will be making adjustments to their professional and personal lives. 
As a result they may have difficulty in meeting the timelines associated with our peer review process. 
Please let the journal editorial office know if you need additional time. Our systems will continue to 
remind you of the original timelines but we intend to be flexible. 
Thank you for choosing to submit your paper to us. These instructions will ensure we have everything 
required so your paper can move through peer review, production and publication smoothly. Please take 
the time to read and follow them as closely as possible, as doing so will ensure your paper matches the 
journal’s requirements.  
This journal uses ScholarOne Manuscripts (previously Manuscript Central) to peer review manuscript 
submissions. Please read the guide for ScholarOne authors before making a submission. Complete 
guidelines for preparing and submitting your manuscript to this journal are provided below.  
This title utilises format-free submission. Authors may submit their paper in any scholarly format or 
layout. References can be in any style or format, so long as a consistent scholarly citation format is 
applied. For more detail see the format-free submission section below . 
About the Journal 
The Clinical Neuropsychologist is an international, peer-reviewed journal publishing high-quality, original 
research. Please see the journal's Aims & Scope for information about its focus and peer-review policy. 
Please note that this journal only publishes manuscripts in English. 
The Clinical Neuropsychologist accepts the following types of article: Original Articles, Review Articles, 
Grand Rounds Articles, Book Reviews.. 
Authors are strongly encouraged to consult the TCN reporting guidelines checklist when preparing or 
editing their manuscript. Gross disregard for the reporting guidelines could result in the manuscript being 
returned without a review. 
Peer Review and Ethics 
Taylor & Francis is committed to peer-review integrity and upholding the highest standards of review. 
Once your paper has been assessed for suitability by the editor, it will then be single blind peer reviewed 
by independent, anonymous expert referees. Find out more about what to expect during peer review 
and read our guidance on publishing ethics . 
Preparing Your Paper 
Structure 
Your paper should be compiled in the following order: title page; abstract; keywords; main text 
introduction, materials and methods, results, discussion; acknowledgments; declaration of interest 
statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; 
figure captions (as a list). 
Word Limits 
Please include a word count for your paper. There are no word limits for papers in this journal. 
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Format-Free Submission 
Authors may submit their paper in any scholarly format or layout. Manuscripts may be supplied as single 
or multiple files. These can be Word, rich text format (rtf), open document format (odt), or PDF files. 
Figures and tables can be placed within the text or submitted as separate documents. Figures should be of 
sufficient resolution to enable refereeing. 
• There are no strict formatting requirements, but all manuscripts must contain the essential 
elements needed to evaluate a manuscript: abstract, author affiliation, figures, tables, funder 
information, and references. Further details may be requested upon acceptance. 
• References can be in any style or format, so long as a consistent scholarly citation format is 
applied. Author name(s), journal or book title, article or chapter title, year of publication, volume 
and issue (where appropriate) and page numbers are essential. All bibliographic entries must 
contain a corresponding in-text citation. The addition of DOI (Digital Object Identifier) numbers is 
recommended but not essential. 
• The journal reference style will be applied to the paper post-acceptance by Taylor & Francis. 
• Spelling can be US or UK English so long as usage is consistent. 
Note that, regardless of the file format of the original submission, an editable version of the article must 
be supplied at the revision stage. 
Taylor & Francis Editing Services 
To help you improve your manuscript and prepare it for submission, Taylor & Francis provides a range of 
editing services. Choose from options such as English Language Editing, which will ensure that your article 
is free of spelling and grammar errors, Translation, and Artwork Preparation. For more information, 
including pricing, visit this website . 
Reporting Guidelines Checklist: What to Include to Facilitate Scientific Rigor and Reproducibility 
In recent years, with the increasing recognition that there is a non-replication crisis in scientific publishing, 
many journals require that authors follow strict reporting guidelines to facilitate reproducibility of 
published studies. TCN reporting guidelines can be found on the link below. We encourage authors to 
print the TCN reporting guidelines checklist and use it to ascertain, in a point-by-point fashion, that all 
scientifically important information is reported in their manuscripts. Click here for a printable Reporting 
Guidelines Checklist.  
Formatting Checklist: What to Include 
1. Author details. All authors of a manuscript should include their full name and affiliation on the 
cover page of the manuscript. Where available, please also include ORCiDs and social media 
handles (Facebook, Twitter or LinkedIn). One author will need to be identified as the 
corresponding author, with their email address normally displayed in the article PDF (depending 
on the journal) and the online article. Authors’ affiliations are the affiliations where the research 
was conducted. If any of the named co-authors moves affiliation during the peer-review process, 
the new affiliation can be given as a footnote. Please note that no changes to affiliation can be 
made after your paper is accepted. Read more on authorship . 
2. Abstract. Should contain a structured abstract of 250 words. A structured abstract should cover 
(in the following order): Objective: A brief statement of the purpose of the study. Method: A 
summary of the participants as well as descriptions of the study design, procedures, and specific 
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key measures, to the extent that space allows. Results: A summary of the key findings. 
Conclusions: Clinical and theoretical implications of the findings. NOTE: If your manuscript is a 
critical review or a commentary, you can omit the Results portion of the abstract. However, 
retain that portion for systematic reviews and meta-analyses. Read tips on writing your abstract. 
3.  
o Graphical abstract (optional). This is an image to give readers a clear idea of the content 
of your article. It should be a maximum width of 525 pixels. If your image is narrower 
than 525 pixels, please place it on a white background 525 pixels wide to ensure the 
dimensions are maintained. Save the graphical abstract as a .jpg, .png, or .tiff. Please do 
not embed it in the manuscript file but save it as a separate file, labelled 
GraphicalAbstract1. 
o Video abstract (optional). 
o Find out how these can help your work reach a wider audience, and what to think 
about when filming. 
4. Between 5 and 10  keywords. Read making your article more discoverable, including information 
on choosing a title and search engine optimization. 
5. Funding details. Please supply all details required by your funding and grant-awarding bodies as 
follows:  
For single agency grants  
This work was supported by the [Funding Agency] under Grant [number xxxx].  
For multiple agency grants  
This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding 
Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx]. 
6. Disclosure statement. This is to acknowledge any financial interest or benefit that has arisen 
from the direct applications of your research. Further guidance on what is a conflict of interest 
and how to disclose it . 
7. Data availability statement. If there is a data set associated with the paper, please provide 
information about where the data supporting the results or analyses presented in the paper can 
be found. Where applicable, this should include the hyperlink, DOI or other persistent identifier 
associated with the data set(s). Templates are also available to support authors. 
8. Data deposition. If you choose to share or make the data underlying the study open, please 
deposit your data in a recognized data repository prior to or at the time of submission. You will 
be asked to provide the DOI, pre-reserved DOI, or other persistent identifier for the data set. 
9. Geolocation information. Submitting a geolocation information section, as a separate paragraph 
before your acknowledgements, means we can index your paper’s study area accurately in 
JournalMap’s geographic literature database and make your article more discoverable to others. 
More information . 
10. Supplemental online material. Supplemental material can be a video, dataset, fileset, sound file 
or anything which supports (and is pertinent to) your paper. We publish supplemental material 
online via Figshare. Find out more about supplemental material and how to submit it with your 
article . 
11. Figures. Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for 
colour, at the correct size). Figures should be supplied in one of our preferred file formats: EPS, 
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PS, JPEG, TIFF, or Microsoft Word (DOC or DOCX) files are acceptable for figures that have been 
drawn in Word. For information relating to other file types, please consult our Submission of 
electronic artwork document. 
12. Tables. Tables should present new information rather than duplicating what is in the text. 
Readers should be able to interpret the table without reference to the text. Please supply 
editable files. 
13. Equations. If you are submitting your manuscript as a Word document, please ensure that 
equations are editable. More information about mathematical symbols and equations . 
14. Units. Please use SI units (non-italicized). 
Using Third-Party Material in your Paper 
You must obtain the necessary permission to reuse third-party material in your article. The use of short 
extracts of text and some other types of material is usually permitted, on a limited basis, for the purposes 
of criticism and review without securing formal permission. If you wish to include any material in your 
paper for which you do not hold copyright, and which is not covered by this informal agreement, you will 
need to obtain written permission from the copyright owner prior to submission. More information on 
requesting permission to reproduce work(s) under copyright . 
Submitting Your Paper 
This journal uses ScholarOne Manuscripts to manage the peer-review process. If you haven't submitted a 
paper to this journal before, you will need to create an account in ScholarOne. Please read the guidelines 
above and then submit your paper in the relevant Author Centre , where you will find user guides and a 
helpdesk. 
Please note that The Clinical Neuropsychologist uses Crossref™ to screen papers for unoriginal material. 
By submitting your paper to The Clinical Neuropsychologist you are agreeing to originality checks during 
the peer-review and production processes. 
On acceptance, we recommend that you keep a copy of your Accepted Manuscript. Find out more about 
sharing your work . 
Data Sharing Policy 
This journal applies the Taylor & Francis Basic Data Sharing Policy. Authors are encouraged to share or 
make open the data supporting the results or analyses presented in their paper where this does not 
violate the protection of human subjects or other valid privacy or security concerns. 
Authors are encouraged to deposit the dataset(s) in a recognized data repository that can mint a 
persistent digital identifier, preferably a digital object identifier (DOI) and recognizes a long-term 
preservation plan. If you are uncertain about where to deposit your data, please see this information 
regarding repositories. 
Authors are further encouraged to cite any data sets referenced in the article and provide a Data 
Availability Statement . 
At the point of submission, you will be asked if there is a data set associated with the paper. If you reply 
yes, you will be asked to provide the DOI, pre-registered DOI, hyperlink, or other persistent identifier 
associated with the data set(s). If you have selected to provide a pre-registered DOI, please be prepared 
to share the reviewer URL associated with your data deposit, upon request by reviewers. 
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Where one or multiple data sets are associated with a manuscript, these are not formally peer reviewed 
as a part of the journal submission process. It is the author’s responsibility to ensure the soundness of 
data. Any errors in the data rest solely with the producers of the data set(s). 
Publication Charges 
There are no submission fees, publication fees or page charges for this journal. 
Colour figures will be reproduced in colour in your online article free of charge. If it is necessary for the 
figures to be reproduced in colour in the print version, a charge will apply. 
Charges for colour figures in print are £300 per figure ($400 US Dollars; $500 Australian Dollars; €350). For 
more than 4 colour figures, figures 5 and above will be charged at £50 per figure ($75 US Dollars; $100 
Australian Dollars; €65). Depending on your location, these charges may be subject to local taxes. 
Copyright Options 
Copyright allows you to protect your original material, and stop others from using your work without your 
permission. Taylor & Francis offers a number of different license and reuse options, including Creative 
Commons licenses when publishing open access. Read more on publishing agreements . 
Complying with Funding Agencies 
We will deposit all National Institutes of Health or Wellcome Trust-funded papers into PubMedCentral on 
behalf of authors, meeting the requirements of their respective open access policies. If this applies to you, 
please tell our production team when you receive your article proofs, so we can do this for you. Check 
funders’ open access policy mandates here. Find out more about sharing your work . 
Open Access 
This journal gives authors the option to publish open access via our Open Select publishing program, 
making it free to access online immediately on publication. Many funders mandate publishing your 
research open access; you can check open access funder policies and mandates here . 
Taylor & Francis Open Select gives you, your institution or funder the option of paying an article 
publishing charge (APC) to make an article open access. Please contact openaccess@tandf.co.uk if you 
would like to find out more, or go to our Author Services website . 
For more information on license options, embargo periods and APCs for this journal please go here . 
My Authored Works 
On publication, you will be able to view, download and check your article’s metrics (downloads, citations 
and Altmetric data) via My Authored Works on Taylor & Francis Online. This is where you can access 
every article you have published with us, as well as your free eprints link, so you can quickly and easily 
share your work with friends and colleagues. 
We are committed to promoting and increasing the visibility of your article. Here are some tips and ideas 
on how you can work with us to promote your research . 
Article Reprints 
You will be sent a link to order article reprints via your account in our production system. For enquiries 
about reprints, please contact the Taylor & Francis Author Services team at reprints@tandf.co.uk. You 
can also order print copies of the journal issue in which your article appears . 
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Queries 
Should you have any queries, please visit our Author Services website or contact us here . 
Updated 18-02-2019  
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Appendix B: PROSPERO Registration Confirmation 
From: CRD-REGISTER <irss505@york.ac.uk> 
Date: 10. february 2020 kl. 15:53:05 CET 
To: "Pernille Myhre (MED - Postgraduate Researcher)" <P.Myhre@uea.ac.uk> 
Topic: PROSPERO Registration message [160049] 
 
Dear Pernille, 
 
Thank you for submitting details of your systematic review "How does 
apathy associate with functional activities after a stroke? A 
systematic review" to the PROSPERO register. We are pleased to 
confirm that the record will be published on our website within the 
next hour. 
 
Your registration number is: CRD42020160049 
 
You are free to update the record at any time, all submitted changes 
will be displayed as the latest version with previous versions 
available to public view. Please also give brief details of the key 
changes in the Revision notes facility and remember to update your 
record when your review is published. You can log in to PROSPERO and 
access your records 
at  https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fww
w.crd.york.ac.uk%2FPROSPERO&amp;data=02%7C01%7Cp.myhre%40uea.
ac.uk%7Cc0fbacd40cf64c35808b08d7ae38ee17%7Cc65f8795ba3d43518a070
865e5d8f090%7C0%7C0%7C637169431852922522&amp;sdata=cD5Z7%2Fe
MXQxBAOgmTGoq2r8hQ9xfeqjmbhVPwl7%2Bq9Q%3D&amp;reserved=0. 
 
Comments and feedback on your experience of registering with PROSPERO 
are welcome at crd-register@york.ac.uk  
 
Is your team looking for a platform to conduct data extraction for 
your systematic review? SRDR-Plus is a free, powerful, easy-to-use 
systematic review data management and archival tool. You can get 
started here: 
https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fsrdrplus.
ahrq.gov&amp;data=02%7C01%7Cp.myhre%40uea.ac.uk%7Cc0fbacd40cf64
c35808b08d7ae38ee17%7Cc65f8795ba3d43518a070865e5d8f090%7C0%7C0
%7C637169431852922522&amp;sdata=y62v2V1YzBQ6ks3OBszZ6mZ%2B7
%2BnglF68AmBnDXN4N5M%3D&amp;reserved=0.  
 
Best wishes for the successful completion of your review. 
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Yours sincerely, 
 
PROSPERO Administrator 
Centre for Reviews and Dissemination 
University of York 
York YO10 5DD 
t: +44 (0) 1904 321049 
e: CRD-register@york.ac.uk 
https://eur01.safelinks.protection.outlook.com/?url=www.york.ac.uk%2Finst%
2Fcrd&amp;data=02%7C01%7Cp.myhre%40uea.ac.uk%7Cc0fbacd40cf64c35
808b08d7ae38ee17%7Cc65f8795ba3d43518a070865e5d8f090%7C0%7C0%7
C637169431852922522&amp;sdata=hopK0fpj%2BbOv5ZCXAEIfa8USKT96
OKb%2Fk8nXNnL8FrA%3D&amp;reserved=0 
 
 
PROSPERO is funded by the National Institute for Health Research and 
produced by CRD, which is an academic department of the University of 
York. 
 
Email disclaimer: 
https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.y
ork.ac.uk%2Fdocs%2Fdisclaimer%2Femail.htm&amp;data=02%7C01%7Cp.
myhre%40uea.ac.uk%7Cc0fbacd40cf64c35808b08d7ae38ee17%7Cc65f8795b
a3d43518a070865e5d8f090%7C0%7C0%7C637169431852922522&amp;sdat
a=MWEWf8RTWymkFrvIrKqi4N2nh1LsU5umC0XTqSVABH4%3D&amp;r
eserved=0 
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Appendix C: NICE Appraisal Checklist 
Quality appraisal checklist – quantitative studies reporting correlations and 
associations 
A correlates review (see section 3.3.4) attempts to establish the factors that are associated or 
correlated with positive or negative health behaviours or outcomes. Evidence for correlate 
reviews will come both from specifically designed correlation studies and other study designs 
that also report on correlations.  
This checklist[15] has been developed for assessing the validity of studies reporting 
correlations. It is based on the appraisal step of the 'Graphical appraisal tool for 
epidemiological studies (GATE)', developed by Jackson et al. (2006). 
This checklist enables a reviewer to appraise a study's internal and external validity after 
addressing the following key aspects of study design: characteristics of study participants; 
definition of independent variables; outcomes assessed and methods of analyses.  
Like GATE, this checklist is intended to be used in an electronic (Excel) format that will 
facilitate both the sharing and storage of data, and through linkage with other documents, the 
compilation of research reports. Much of the guidance to support the completion of the critical 
appraisal form that is reproduced below also appears in 'pop-up' windows in the electronic 
version[16].  
There are 5 sections of the revised GATE. Section 1 seeks to assess the key population criteria 
for determining the study's external validity – that is, the extent to which the findings of a 
study are generalisable beyond the confines of the study to the study's source population. 
Sections 2 to 4 assess the key criteria for determining the study's internal validity – that is, 
making sure that the study has been carried out carefully, and that the identified associations 
are valid and are not due to some other (often unidentified) factor.  
Checklist items are worded so that 1 of 5 responses is possible: 
++  Indicates that for that particular aspect of study design, the study has been 
designed or conducted in such a way as to minimise the risk of bias. 
+  Indicates that either the answer to the checklist question is not clear from the 
way the study is reported, or that the study may not have addressed all 
potential sources of bias for that particular aspect of study design. 
−  Should be reserved for those aspects of the study design in which significant 
sources of bias may persist. 
Not reported 
(NR)  
Should be reserved for those aspects in which the study under review fails to 
report how they have (or might have) been considered. 
Not 
applicable 
(NA)  
Should be reserved for those study design aspects that are not applicable 
given the study design under review (for example, allocation concealment 
would not be applicable for case–control studies).  
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In addition, the reviewer is requested to complete in detail the comments section of the quality 
appraisal form so that the grade awarded for each study aspect is as transparent as possible.  
Each study is then awarded an overall study quality grading for internal validity (IV) and a 
separate one for external validity (EV):  
• ++ All or most of the checklist criteria have been fulfilled, where they have not been 
fulfilled the conclusions are very unlikely to alter. 
• + Some of the checklist criteria have been fulfilled, where they have not been fulfilled, 
or not adequately described, the conclusions are unlikely to alter. 
• – Few or no checklist criteria have been fulfilled and the conclusions are likely or very 
likely to alter. 
Checklist 
Study identification: Include full citation details   
Study design:  
• Refer to the glossary of study designs and the algorithm for 
classifying experimental and observational study designs to best 
describe the paper's underpinning study design 
 
Guidance topic:  
 
Assessed by:  
 
Section 1: Population  
1.1 Is the source population or source area well described?  
• Was the country (e.g. developed or non-developed, type of health 
care system), setting (primary schools, community centres etc), 
location (urban, rural), population demographics etc adequately 
described? 
++ 
+ 
− 
NR 
NA 
Comments: 
1.2 Is the eligible population or area representative of the source 
population or area?  
• Was the recruitment of individuals, clusters or areas well defined 
(e.g. advertisement, birth register)?  
• Was the eligible population representative of the source? Were 
important groups underrepresented? 
++ 
+ 
− 
NR 
NA 
Comments: 
1.3 Do the selected participants or areas represent the eligible 
population or area?  
++ 
+ 
Comments: 
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• Was the method of selection of participants from the eligible 
population well described? 
• What % of selected individuals or clusters agreed to participate? 
Were there any sources of bias? 
• Were the inclusion or exclusion criteria explicit and appropriate? 
− 
NR 
NA 
Section 2: Method of selection of exposure (or comparison) group  
2.1 Selection of exposure (and comparison) group. How was selection 
bias minimised?  
• How was selection bias minimised? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.2 Was the selection of explanatory variables based on a sound 
theoretical basis?  
• How sound was the theoretical basis for selecting the explanatory 
variables? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.3 Was the contamination acceptably low?  
• Did any in the comparison group receive the exposure?  
• If so, was it sufficient to cause important bias? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.4 How well were likely confounding factors identified and controlled?  
• Were there likely to be other confounding factors not considered or 
appropriately adjusted for? 
• Was this sufficient to cause important bias? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.5 Is the setting applicable to the UK?  ++ Comments: 
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• Did the setting differ significantly from the UK? + 
− 
NR 
NA 
Section 3: Outcomes  
3.1 Were the outcome measures and procedures reliable?  
• Were outcome measures subjective or objective (e.g. biochemically 
validated nicotine levels ++ vs self-reported smoking −)? 
• How reliable were outcome measures (e.g. inter- or intra-rater 
reliability scores)? 
• Was there any indication that measures had been validated (e.g. 
validated against a gold standard measure or assessed for content 
validity)? 
++ 
+ 
− 
NR 
NA 
Comments: 
3.2 Were the outcome measurements complete?  
• Were all or most of the study participants who met the defined 
study outcome definitions likely to have been identified? 
++ 
+ 
− 
NR 
NA 
Comments: 
3.3 Were all the important outcomes assessed?  
• Were all the important benefits and harms assessed?  
• Was it possible to determine the overall balance of benefits and 
harms of the intervention versus comparison? 
++ 
+ 
− 
NR 
NA 
Comments: 
3.4 Was there a similar follow-up time in exposure and comparison 
groups?  
• If groups are followed for different lengths of time, then more 
events are likely to occur in the group followed-up for longer 
distorting the comparison.  
• Analyses can be adjusted to allow for differences in length of 
follow-up (e.g. using person-years). 
++ 
+ 
− 
NR 
NA 
Comments: 
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3.5 Was follow-up time meaningful?  
• Was follow-up long enough to assess long-term benefits and harms?  
• Was it too long, e.g. participants lost to follow-up? 
++ 
+ 
− 
NR 
NA 
Comments: 
Section 4: Analyses  
4.1 Was the study sufficiently powered to detect an intervention effect 
(if one exists)?  
• A power of 0.8 (i.e. it is likely to see an effect of a given size if one 
exists, 80% of the time) is the conventionally accepted standard. 
• Is a power calculation presented? If not, what is the expected effect 
size? Is the sample size adequate? 
++ 
+ 
− 
NR 
NA 
Comments: 
4.2 Were multiple explanatory variables considered in the analyses?  
• Were there sufficient explanatory variables considered in the 
analysis?  
++ 
+ 
− 
NR 
NA 
Comments: 
4.3 Were the analytical methods appropriate?  
• Were important differences in follow-up time and likely 
confounders adjusted for?  
++ 
+ 
− 
NR 
NA 
Comments: 
4.6 Was the precision of association given or calculable? Is association 
meaningful?  
• Were confidence intervals or p values for effect estimates given or 
possible to calculate?  
• Were CIs wide or were they sufficiently precise to aid decision-
making? If precision is lacking, is this because the study is under-
powered? 
++ 
+ 
− 
NR 
NA 
Comments: 
Section 5: Summary  
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5.1 Are the study results internally valid (i.e. unbiased)?  
• How well did the study minimise sources of bias (i.e. adjusting for 
potential confounders)?  
• Were there significant flaws in the study design? 
++ 
+ 
− 
Comments: 
5.2 Are the findings generalisable to the source population (i.e. 
externally valid)?  
• Are there sufficient details given about the study to determine if the 
findings are generalisable to the source population?  
• Consider: participants, interventions and comparisons, outcomes, 
resource and policy implications. 
++ 
+ 
− 
Comments: 
 
 
[15] Appraisal form derived from: Jackson R, Ameratunga S, Broad J et al. (2006) The GATE 
frame: critical appraisal with pictures. Evidence Based Medicine 11: 35–8. 
[16] Available from CPHE on request. 
 
NICE. (2012). Methods for the development of NICE public health guidance (third edition). 
Retrieved from https://www.nice.org.uk/process/pmg4/chapter/appendix-f-quality-
appraisal-checklist-quantitative-intervention-studies 
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Appendix D: Power Calculation 
 
To explore how all variables of interest is associated with each other across all 
conditions, G*Power 3.1.9.4 (Faul, 2007) was used to calculate required sample size for the 
mixed design ANOVA. Power was set to 0.95, alpha was set to 0.05. A medium effect size is 
considered a conventional estimate, which yielded an estimated sample size of 44 
participants. Following is a screenshot of the calculation window in the programme.  
 
 
 
 
Faul, F., Erdfelder, E., Lang, A.-G. & Buchner, A. (2007). G*Power 3: A flexible statistical 
 power analysis program for the social, behavioral, and biomedical sciences. Behavior 
 Research Methods, 39, 175-191. 
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Appendix E: Instruction to Authors for Publication in Neurological Sciences 
Instructions for Authors 
Original papers should have a structured abstract, must not exceed 3,000 words and should 
not include more than 4-6 illustrations and tables. Each separate part of a figure (a, b, etc.) 
counts as an illustration. Up to 40 references are permitted. 
Submission of a manuscript implies: that the work described has not been published before; 
that it is not under consideration for publication anywhere else; that its publication has been 
approved by all co-authors, if any, as well as by the responsible authorities – tacitly or 
explicitly – at the institute where the work has been carried out. The publisher will not be held 
legally responsible should there be any claims for compensation. 
Permissions 
Authors wishing to include figures, tables, or text passages that have already been published 
elsewhere are required to obtain permission from the copyright owner(s) for both the print and 
online format and to include evidence that such permission has been granted when submitting 
their papers. Any material received without such evidence will be assumed to originate from 
the authors. 
Online Submission 
Please follow the hyperlink “Submit online” on the right and upload all of your manuscript 
files following the instructions given on the screen. 
Please ensure you provide all relevant editable source files. Failing to submit these source 
files might cause unnecessary delays in the review and production process. 
ORCID ID 
This publication requires that the corresponding author provides his/her ORCiD ID before 
proceeding with submission. 
For more information about this journal’s ORCiD policy, please visit the ORCID FAQ 
Title page 
Title Page 
Please use this template title page for providing the following information.  
The title page should include: 
• The name(s) of the author(s) 
• A concise and informative title 
• The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country 
• A clear indication and an active e-mail address of the corresponding author 
• If available, the 16-digit ORCID of the author(s) 
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If address information is provided with the affiliation(s) it will also be published. 
For authors that are (temporarily) unaffiliated we will only capture their city and country of 
residence, not their e-mail address unless specifically requested. 
Abstract 
Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined 
abbreviations or unspecified references. 
For life science journals only (when applicable) 
Trial registration number and date of registration  
Trial registration number, date of registration followed by “retrospectively registered”  
Keywords 
Please provide 4 to 6 keywords which can be used for indexing purposes. 
Declarations 
All manuscripts must contain the following sections under the heading 'Declarations'.  
If any of the sections are not relevant to your manuscript, please include the heading and write 
'Not applicable' for that section. 
Text 
Text Formatting 
Manuscripts should be submitted in Word. 
• Use a normal, plain font (e.g., 10-point Times Roman) for text. 
• Use italics for emphasis. 
• Use the automatic page numbering function to number the pages. 
• Do not use field functions. 
• Use tab stops or other commands for indents, not the space bar. 
• Use the table function, not spreadsheets, to make tables. 
• Use the equation editor or MathType for equations. 
• Save your file in docx format (Word 2007 or higher) or doc format (older Word 
versions). 
Headings 
Please use no more than three levels of displayed headings. 
Abbreviations 
Abbreviations should be defined at first mention and used consistently thereafter. 
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Acknowledgments 
Acknowledgments of people, grants, funds, etc. should be placed in a separate section on the 
title page. The names of funding organizations should be written in full. 
References 
Citation 
Reference citations in the text should be identified by numbers in square brackets. Some 
examples: 
1. Negotiation research spans many disciplines [3]. 
2. This result was later contradicted by Becker and Seligman [5]. 
3. This effect has been widely studied [1-3, 7]. 
Reference list 
The list of references should only include works that are cited in the text and that have been 
published or accepted for publication. Personal communications and unpublished works 
should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a 
reference list. 
Tables 
• All tables are to be numbered using Arabic numerals. 
• Tables should always be cited in text in consecutive numerical order.  
• For each table, please supply a table caption (title) explaining the components of the 
table. 
• Identify any previously published material by giving the original source in the form of 
a reference at the end of the table caption. 
• Footnotes to tables should be indicated by superscript lower-case letters (or asterisks 
for significance values and other statistical data) and included beneath the table body. 
Artwork and Illustrations Guidelines 
Electronic Figure Submission 
• Supply all figures electronically. 
• Indicate what graphics program was used to create the artwork. 
• For vector graphics, the preferred format is EPS; for halftones, please use TIFF 
format. MSOffice files are also acceptable. 
• Vector graphics containing fonts must have the fonts embedded in the files. 
• Name your figure files with "Fig" and the figure number, e.g., Fig1.eps. 
Line Art 
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• Definition: Black and white graphic with no shading. 
• Do not use faint lines and/or lettering and check that all lines and lettering within the 
figures are legible at final size. 
• All lines should be at least 0.1 mm (0.3 pt) wide. 
• Scanned line drawings and line drawings in bitmap format should have a minimum 
resolution of 1200 dpi. 
• Vector graphics containing fonts must have the fonts embedded in the files. 
Figure Lettering 
• To add lettering, it is best to use Helvetica or Arial (sans serif fonts). 
• Keep lettering consistently sized throughout your final-sized artwork, usually about 2–
3 mm (8–12 pt). 
• Variance of type size within an illustration should be minimal, e.g., do not use 8-pt 
type on an axis and 20-pt type for the axis label. 
• Avoid effects such as shading, outline letters, etc. 
• Do not include titles or captions within your illustrations. 
Figure Numbering 
• All figures are to be numbered using Arabic numerals. 
• Figures should always be cited in text in consecutive numerical order. 
• Figure parts should be denoted by lowercase letters (a, b, c, etc.). 
• If an appendix appears in your article and it contains one or more figures, continue the 
consecutive numbering of the main text. Do not number the appendix figures,"A1, A2, 
A3, etc." Figures in online appendices (Electronic Supplementary Material) should, 
however, be numbered separately. 
Figure Captions 
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• Each figure should have a concise caption describing accurately what the figure 
depicts. Include the captions in the text file of the manuscript, not in the figure file. 
• Figure captions begin with the term Fig. in bold type, followed by the figure number, 
also in bold type. 
• No punctuation is to be included after the number, nor is any punctuation to be placed 
at the end of the caption. 
• Identify all elements found in the figure in the figure caption; and use boxes, circles, 
etc., as coordinate points in graphs. 
• Identify previously published material by giving the original source in the form of a 
reference citation at the end of the figure caption. 
Figure Placement and Size 
• Figures should be submitted separately from the text, if possible. 
• When preparing your figures, size figures to fit in the column width. 
• For large-sized journals the figures should be 84 mm (for double-column text areas), 
or 174 mm (for single-column text areas) wide and not higher than 234 mm. 
• For small-sized journals, the figures should be 119 mm wide and not higher than 195 
mm. 
Permissions 
If you include figures that have already been published elsewhere, you must obtain 
permission from the copyright owner(s) for both the print and online format. Please be aware 
that some publishers do not grant electronic rights for free and that Springer will not be able 
to refund any costs that may have occurred to receive these permissions. In such cases, 
material from other sources should be used. 
Accessibility 
In order to give people of all abilities and disabilities access to the content of your figures, 
please make sure that 
• All figures have descriptive captions (blind users could then use a text-to-speech 
software or a text-to-Braille hardware) 
• Patterns are used instead of or in addition to colors for conveying information 
(colorblind users would then be able to distinguish the visual elements) 
• Any figure lettering has a contrast ratio of at least 4.5:1 
Ethical Responsibilities of Authors 
This journal is committed to upholding the integrity of the scientific record. As a member of 
the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on 
how to deal with potential acts of misconduct.  
Authors should refrain from misrepresenting research results which could damage the trust in 
the journal, the professionalism of scientific authorship, and ultimately the entire scientific 
endeavour. Maintaining integrity of the research and its presentation is helped by following 
the rules of good scientific practice, which include*: 
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• The manuscript should not be submitted to more than one journal for simultaneous 
consideration.  
• The submitted work should be original and should not have been published elsewhere 
in any form or language (partially or in full), unless the new work concerns an 
expansion of previous work. (Please provide transparency on the re-use of material to 
avoid the concerns about text-recycling (‘self-plagiarism’). 
• A single study should not be split up into several parts to increase the quantity of 
submissions and submitted to various journals or to one journal over time (i.e. ‘salami-
slicing/publishing’). 
• Concurrent or secondary publication is sometimes justifiable, provided certain 
conditions are met. Examples include: translations or a manuscript that is intended for 
a different group of readers.  
• Results should be presented clearly, honestly, and without fabrication, falsification or 
inappropriate data manipulation (including image based manipulation). Authors 
should adhere to discipline-specific rules for acquiring, selecting and processing data. 
• No data, text, or theories by others are presented as if they were the author’s own 
(‘plagiarism’). Proper acknowledgements to other works must be given (this includes 
material that is closely copied (near verbatim), summarized and/or paraphrased), 
quotation marks (to indicate words taken from another source) are used for verbatim 
copying of material, and permissions secured for material that is copyrighted.  
Important note: the journal may use software to screen for plagiarism. 
• Authors should make sure they have permissions for the use of software, 
questionnaires/(web) surveys and scales in their studies (if appropriate). 
• Authors should avoid untrue statements about an entity (who can be an individual 
person or a company) or descriptions of their behavior or actions that could potentially 
be seen as personal attacks or allegations about that person.  
• Research that may be misapplied to pose a threat to public health or national security 
should be clearly identified in the manuscript (e.g. dual use of research). Examples 
include creation of harmful consequences of biological agents or toxins, disruption of 
immunity of vaccines, unusual hazards in the use of chemicals, weaponization of 
research/technology (amongst others). 
• Authors are strongly advised to ensure the author group, the Corresponding Author, 
and the order of authors are all correct at submission. Adding and/or deleting authors 
during the revision stages is generally not permitted, but in some cases may be 
warranted. Reasons for changes in authorship should be explained in detail. Please 
note that changes to authorship cannot be made after acceptance of a manuscript. 
*All of the above are guidelines and authors need to make sure to respect third parties rights 
such as copyright and/or moral rights. 
Upon request authors should be prepared to send relevant documentation or data in order to 
verify the validity of the results presented. This could be in the form of raw data, samples, 
records, etc. Sensitive information in the form of confidential or proprietary data is excluded. 
If there is suspicion of misbehavior or alleged fraud the Journal and/or Publisher will carry 
out an investigation following COPE guidelines. If, after investigation, there are valid 
concerns, the author(s) concerned will be contacted under their given e-mail address and 
given an opportunity to address the issue. Depending on the situation, this may result in the 
POST-STROKE APATHY   149 
 
Journal’s and/or Publisher’s implementation of the following measures, including, but not 
limited to:  
• If the manuscript is still under consideration, it may be rejected and returned to the 
author.  
• If the article has already been published online, depending on the nature and severity 
of the infraction:  
- an erratum/correction may be placed with the article 
- an expression of concern may be placed with the article 
- or in severe cases retraction of the article may occur. 
The reason will be given in the published erratum/correction, expression of concern or 
retraction note. Please note that retraction means that the article is maintained on the 
platform, watermarked “retracted” and the explanation for the retraction is provided in a note 
linked to the watermarked article. 
• The author’s institution may be informed 
• A notice of suspected transgression of ethical standards in the peer review system may 
be included as part of the author’s and article’s bibliographic record. 
Fundamental errors 
Authors have an obligation to correct mistakes once they discover a significant error or 
inaccuracy in their published article. The author(s) is/are requested to contact the journal and 
explain in what sense the error is impacting the article. A decision on how to correct the 
literature will depend on the nature of the error. This may be a correction or retraction. The 
retraction note should provide transparency which parts of the article are impacted by the 
error. 
Suggesting / excluding reviewers 
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain 
individuals when they submit their manuscripts. When suggesting reviewers, authors should 
make sure they are totally independent and not connected to the work in any way. It is 
strongly recommended to suggest a mix of reviewers from different countries and different 
institutions. When suggesting reviewers, the Corresponding Author must provide an 
institutional email address for each suggested reviewer, or, if this is not possible to include 
other means of verifying the identity such as a link to a personal homepage, a link to the 
publication record or a researcher or author ID in the submission letter. Please note that the 
Journal may not use the suggestions, but suggestions are appreciated and may help facilitate 
the peer review process. 
Authorship principles 
These guidelines describe authorship principles and good authorship practices to which 
prospective authors should adhere to. 
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Authorship clarified 
The Journal and Publisher assume all authors agreed with the content and that all gave explicit 
consent to submit and that they obtained consent from the responsible authorities at the 
institute/organization where the work has been carried out, before the work is submitted. 
The Publisher does not prescribe the kinds of contributions that warrant authorship. It is 
recommended that authors adhere to the guidelines for authorship that are applicable in their 
specific research field. In absence of specific guidelines it is recommended to adhere to the 
following guidelines*: 
All authors whose names appear on the submission  
1) made substantial contributions to the conception or design of the work; or the acquisition, 
analysis, or interpretation of data; or the creation of new software used in the work; 
2) drafted the work or revised it critically for important intellectual content;  
3) approved the version to be published; and  
4) agree to be accountable for all aspects of the work in ensuring that questions related to the 
accuracy or integrity of any part of the work are appropriately investigated and resolved.  
* Based on/adapted from: 
ICMJE, Defining the Role of Authors and Contributors,  
Transparency in authors’ contributions and responsibilities to promote integrity in scientific 
publication, McNutt at all, PNAS February 27, 2018  
Disclosures and declarations 
All authors are requested to include information regarding sources of funding, financial or 
non-financial interests, study-specific approval by the appropriate ethics committee for 
research involving humans and/or animals, informed consent if the research involved human 
participants, and a statement on welfare of animals if the research involved animals (as 
appropriate). 
The decision whether such information should be included is not only dependent on the scope 
of the journal, but also the scope of the article. Work submitted for publication may have 
implications for public health or general welfare and in those cases it is the responsibility of 
all authors to include the appropriate disclosures and declarations. 
Data transparency 
All authors are requested to make sure that all data and materials as well as software 
application or custom code support their published claims and comply with field standards. 
Please note that journals may have individual policies on (sharing) research data in 
concordance with disciplinary norms and expectations. Please check the Instructions for 
Authors of the Journal that you are submitting to for specific instructions. 
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Role of the Corresponding Author 
One author is assigned as Corresponding Author and acts on behalf of all co-authors and 
ensures that questions related to the accuracy or integrity of any part of the work are 
appropriately addressed.  
The Corresponding Author is responsible for the following requirements: 
• ensuring that all listed authors have approved the manuscript before submission, 
including the names and order of authors; 
• managing all communication between the Journal and all co-authors, before and after 
publication;* 
• providing transparency on re-use of material and mention any unpublished material 
(for example manuscripts in press) included in the manuscript in a cover letter to the 
Editor; 
• making sure disclosures, declarations and transparency on data statements from all 
authors are included in the manuscript as appropriate (see above). 
* The requirement of managing all communication between the journal and all co-authors 
during submission and proofing may be delegated to a Contact or Submitting Author. In this 
case please make sure the Corresponding Author is clearly indicated in the manuscript. 
Author contributions 
Please check the Instructions for Authors of the Journal that you are submitting to for specific 
instructions regarding contribution statements. 
In absence of specific instructions and in research fields where it is possible to describe 
discrete efforts, the Publisher recommends authors to include contribution statements in the 
work that specifies the contribution of every author in order to promote transparency. These 
contributions should be listed at the separate title page. 
Examples of such statement(s) are shown below: 
• Free text: 
All authors contributed to the study conception and design. Material preparation, data 
collection and analysis were performed by [full name], [full name] and [full name]. The first 
draft of the manuscript was written by [full name] and all authors commented on previous 
versions of the manuscript. All authors read and approved the final manuscript. 
Example: CRediT taxonomy:  
• Conceptualization: [full name], …; Methodology: [full name], …; Formal analysis and 
investigation: [full name], …; Writing - original draft preparation: [full name, …]; Writing - 
review and editing: [full name], …; Funding acquisition: [full name], …; Resources: [full 
name], …; Supervision: [full name],…. 
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For review articles where discrete statements are less applicable a statement should be 
included who had the idea for the article, who performed the literature search and data 
analysis, and who drafted and/or critically revised the work.  
For articles that are based primarily on the student’s dissertation or thesis, it is 
recommended that the student is usually listed as principal author:  
A Graduate Student’s Guide to Determining Authorship Credit and Authorship Order, APA 
Science Student Council 2006  
Affiliation 
The primary affiliation for each author should be the institution where the majority of their 
work was done. If an author has subsequently moved, the current address may additionally be 
stated. Addresses will not be updated or changed after publication of the article. 
Changes to authorship 
Authors are strongly advised to ensure the correct author group, the Corresponding Author, 
and the order of authors at submission. Changes of authorship by adding or deleting authors, 
and/or changes in Corresponding Author, and/or changes in the sequence of authors are not 
accepted after acceptance of a manuscript.  
• Please note that author names will be published exactly as they appear on the 
accepted submission! 
Please make sure that the names of all authors are present and correctly spelled, and that 
addresses and affiliations are current.  
Adding and/or deleting authors at revision stage are generally not permitted, but in some cases 
it may be warranted. Reasons for these changes in authorship should be explained. Approval 
of the change during revision is at the discretion of the Editor-in-Chief. Please note that 
journals may have individual policies on adding and/or deleting authors during revision stage. 
Author identification 
Authors are recommended to use their ORCID ID when submitting an article for 
consideration or acquire an ORCID ID via the submission process.  
Deceased or incapacitated authors 
For cases in which a co-author dies or is incapacitated during the writing, submission, or peer-
review process, and the co-authors feel it is appropriate to include the author, co-authors 
should obtain approval from a (legal) representative which could be a direct relative. 
Authorship issues or disputes 
In the case of an authorship dispute during peer review or after acceptance and publication, 
the Journal will not be in a position to investigate or adjudicate. Authors will be asked to 
resolve the dispute themselves. If they are unable the Journal reserves the right to withdraw a 
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manuscript from the editorial process or in case of a published paper raise the issue with the 
authors’ institution(s) and abide by its guidelines. 
Confidentiality 
Authors should treat all communication with the Journal as confidential which includes 
correspondence with direct representatives from the Journal such as Editors-in-Chief and/or 
Handling Editors and reviewers’ reports unless explicit consent has been received to share 
information. 
Compliance with Ethical Standards 
To ensure objectivity and transparency in research and to ensure that accepted principles of 
ethical and professional conduct have been followed, authors should include information 
regarding sources of funding, potential conflicts of interest (financial or non-financial), 
informed consent if the research involved human participants, and a statement on welfare of 
animals if the research involved animals. 
Authors should include the following statements (if applicable) in a separate section entitled 
“Compliance with Ethical Standards” when submitting a paper: 
• Disclosure of potential conflicts of interest  
• Research involving Human Participants and/or Animals 
• Informed consent  
Please note that standards could vary slightly per journal dependent on their peer review 
policies (i.e. single or double blind peer review) as well as per journal subject discipline. 
Before submitting your article check the instructions following this section carefully. 
The corresponding author should be prepared to collect documentation of compliance with 
ethical standards and send if requested during peer review or after publication. 
The Editors reserve the right to reject manuscripts that do not comply with the above-
mentioned guidelines. The author will be held responsible for false statements or failure to 
fulfill the above-mentioned guidelines. 
Disclosure of potential conflicts of interest 
Authors must disclose all relationships or interests that could influence or bias the work. 
Although an author may not feel there are conflicts, disclosure of relationships and interests 
affords a more transparent process, leading to an accurate and objective assessment of the 
work. Awareness of real or perceived conflicts of interests is a perspective to which the 
readers are entitled and is not meant to imply that a financial relationship with an organization 
that sponsored the research or compensation for consultancy work is inappropriate. Examples 
of potential conflicts of interests that are directly or indirectly related to the research may 
include but are not limited to the following: 
• Research grants from funding agencies (please give the research funder and the grant 
number) 
• Honoraria for speaking at symposia 
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• Financial support for attending symposia 
• Financial support for educational programs 
• Employment or consultation 
• Support from a project sponsor  
• Position on advisory board or board of directors or other type of management 
relationships 
• Multiple affiliations 
• Financial relationships, for example equity ownership or investment interest 
• Intellectual property rights (e.g. patients, copyrights and royalties from such rights) 
• Holdings of spouse and/or children that may have financial interest in the work 
In addition, interests that go beyond financial interests and compensation (non-financial 
interests) that may be important to readers should be disclosed. These may include but are not 
limited to personal relationships or competing interests directly or indirectly tied to this 
research, or professional interests or personal beliefs that may influence your research. 
The corresponding author collects the conflict of interest disclosure forms from all authors. In 
author collaborations where formal agreements for representation allow it, it is sufficient for 
the corresponding author to sign the disclosure form on behalf of all authors. Examples of 
forms can be found 
here:  
The corresponding author will include a summary statement on the title page that is 
separate from their manuscript, that reflects what is recorded in the potential conflict of 
interest disclosure form(s).  
See below examples of disclosures: 
Funding: This study was funded by X (grant number X). 
Conflict of Interest: Author A has received research grants from Company A. Author B has 
received a speaker honorarium from Company X and owns stock in Company Y. Author C is 
a member of committee Z.  
If no conflict exists, the authors should state:  
Conflict of Interest: The authors declare that they have no conflict of interest. 
Research involving human participants, their data or biological material 
Ethics approval 
When reporting a study that involved human participants, their data or biological material, 
authors should include a statement that confirms that the study was approved (or granted 
exemption) by the appropriate institutional and/or national research ethics committee 
(including the name of the ethics committee) and certify that the study was performed in 
accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its 
later amendments or comparable ethical standards. If doubt exists whether the research was 
conducted in accordance with the 1964 Helsinki Declaration or comparable standards, the 
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authors must explain the reasons for their approach, and demonstrate that an independent 
ethics committee or institutional review board explicitly approved the doubtful aspects of the 
study. If a study was granted exemption from requiring ethics approval, this should also be 
detailed in the manuscript (including the reasons for the exemption). 
Summary of requirements 
The above should be summarized in a statement and included on a title page that is separate 
from the manuscript with a section entitled “Declarations” when submitting a paper. 
Having all statements in one place allows for a consistent and unified review of the 
information by the Editor-in-Chief and/or peer reviewers and may speed up the handling of 
the paper. Declarations include Funding, Conflicts of interest/competing interests, Ethics 
approval, Consent, Data and/or Code availability and Authors’ contribution statements. 
Please use the following template title page for providing the statements.  
Once and if the paper is accepted for publication, the production department will put the 
respective statements in a distinctly identified section clearly visible for readers. 
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Appendix F: Poster for Recruitment  
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Appendix G: Participant Information Sheet 
Participant Information Sheet for Stroke Survivors 
 
Please take time to read the following information so that you may understand why this 
research is being done. 
What is the purpose of the study? 
Apathy is a lack of motivation, where people can have problems in starting things, problems 
with finishing things or can be emotionally neutral to things. Demotivation in the form of 
apathy is quite common following a stroke and is observed in about 20 – 40% of patients. 
Apathy can be an obstacle to stroke rehabilitation, as it causes difficulties in finding the 
motivation to participate in rehabilitation and treatment after stroke.  Evidence has suggested 
that there may be different types of apathy and there is currently no effective method for 
measuring these different types of apathy after stroke. This study will validate an apathy 
questionnaire for stroke survivors and test if it is a suitable assessment tool for identifying and 
profiling post-stroke apathy. 
Why have I been chosen? 
We will be recruiting about one hundred stroke survivors for this study. We would like to ask 
you to complete some questionnaires in relation to your motivation, mood and everyday 
activities. 
Do I have to take part? 
No, it is your choice whether to take part or not. If you decide to do so, please tick the box to 
continue. If you do not wish to participate, close this window. Please keep in mind that your 
participation in this study is voluntary so you may withdraw from the study at any time 
without explanation up until you click “submit” at the end of the questionnaire. 
What do I have to do? 
Participation in this study involves completing the questions in this online survey. Please read 
the instructions at the beginning of each questionnaire carefully before completing them. The 
questionnaire should take approximately 20 minutes in total to complete. Once you have 
completed please press “submit”.  There is no further participation in the study. 
What are the possible disadvantages and risks of taking part? 
There will be no direct benefit to you for participating in this study. Your individual results 
will not be revealed to you but any future publications of the findings from this research will 
be made available to you. The hope for this research is that it will improve knowledge about 
demotivational symptoms related to stroke.                                                             
What if I experience discomfort while completing the questionnaires? 
While it is not anticipated that you will be uncomfortable in completing the questionnaires, 
you may contact: 
Pernille Myhre 
Email: stroke.psyresearch@uea.ac.uk 
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Will my taking part in this study be kept confidential? 
All information collected for the duration of this study will be kept strictly confidential. None 
of the information you provide will be directly associated with your personal information. 
What will happen to the results of the research study? 
The results of this study will be published in suitable peer-reviewed scientific journals. Talks 
and presentations may be made at meetings and conferences. Your personal details will not be 
revealed in every one of these cases. 
Who is organising the research? 
This study is being organised by Pernille Myhre, Dr. Catherine Ford and Dr. Ratko Radakovic 
from the University of East Anglia (UEA). 
Who has reviewed this study? 
This study has been granted approval by the FMH Ethics committee at UEA. 
Prize draw 
If you choose to take part in the study, you may be entered in to a prize draw where you could 
win one of five £25 Amazon Vouchers. You enter by adding your email address on the next 
page, but this is completely voluntary. 
Contact for Further information 
If you have any further questions about the study at any time or, at a later date, the outcome of 
the study: 
Pernille Myhre 
Email: stroke.psyresearch@uea.ac.uk 
Members of the study team: 
Pernille Myhre, Trainee Clinical Psychologist1 
Supervisors: Dr Catherine Ford, Clinical Lecturer in Psychology 1 
Dr Ratko Radakovic, Neuropsychology researcher1 
Research Panel: Dr Fergus Gracey, Senior Research Fellow1 
Collaborators: Dr Andrew Bateman, Reader and Director NIHR Research Design Service2 & 
Dr Sara Simblett, Postdoctoral Research Associate3 
1Dept of Clinical and Applied Psychology, UEA, 2School of Health and Social Care, 
University of Essex, 3Institute of Psychiatry, Psychology and Neuroscience, London 
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Participant Information Sheet for Control group 
 
Study title: Profiling Apathy After Stroke 
Please take time to read the following information so that you may understand why this 
research is being done. 
What is the purpose of the study? 
Apathy is a lack of motivation, where people can have problems in starting things, problems 
with finishing things or can be emotionally neutral to things. Demotivation in the form of 
apathy is quite common following a stroke and is observed in about 20 – 40% of patients. 
Apathy can be an obstacle to stroke rehabilitation, as it causes difficulties in finding the 
motivation to participate in rehabilitation and treatment after stroke. Evidence has suggested 
that there may be different types of apathy and there is currently no effective method for 
measuring different types of apathy after stroke. This study will validate an apathy 
questionnaire for stroke survivors and test if it is a suitable assessment tool for identifying and 
profiling post-stroke apathy. 
Why have I been chosen? 
We will be recruiting about one hundred healthy participants who have not experienced a 
stroke. 
Do I have to take part? 
No, it is your choice whether to take part or not. If you decide to do so, please tick “next” to 
continue. If you do not wish to participate, close this window. Please keep in mind that your 
participation in this study is voluntary so you may withdraw from the study at any time 
without explanation up until you click submit. 
What do I have to do? 
Participation in this study involves completing the questions in this online survey. Please read 
the instructions at the beginning of each questionnaire carefully before completing them. The 
questionnaire should take up to 15 minutes in total to complete. Once you have completed 
please press “submit”.  There is no further participation in the study. 
What are the possible disadvantages and risks of taking part? 
There will be no direct benefit to you in taking part. Your individual results will not be 
revealed to you but any future publications of the findings from this research will be made 
available to you. The hope for this research is that it will improve knowledge about 
demotivational symptoms related with stroke. 
What if I experience discomfort while completing the questionnaires? 
While it is not anticipated that you will be uncomfortable in completing the questionnaires, 
you may contact: 
Pernille Myhre 
Email: stroke.psyresearch@uea.ac.uk 
Will my taking part in this study be kept confidential? 
All information collected for the duration of this study will be kept strictly confidential. You 
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will be given an identification code to keep your details anonymous throughout the study and 
any future publications. 
What will happen to the results of the research study? 
The results of this study will be published in suitable peer-reviewed scientific journals. Talks 
and presentations may be made at meetings and conferences. Your personal details will not be 
revealed in any one of these cases. 
Who is organising the research? 
This study is being organised by Pernille Myhre, Dr. Catherine Ford and Dr. Ratko Radakovic 
from the University of East Anglia (UEA). 
Who has reviewed this study? 
This study has been granted approval by the FMH Ethics committee at UEA 
Prize draw 
If you choose to take part in the study, you may be entered into a prize draw where you could 
win one of five £25 Amazon Vouchers. You enter by adding your email address on the next 
page, but this is completely voluntary. 
Contact for Further information 
If you have any further questions about the study at any time or, at a later date, the outcome of 
the study: 
Pernille Myhre 
Email:  stroke.psyresearch@uea.ac.uk 
Members of the study team: 
Pernille Myhre, Trainee Clinical Psychologist1 
Supervisors: Dr Catherine Ford, Clinical Lecturer in Psychology 1 
Dr Ratko Radakovic, Neuropsychology researcher1 
Research Panel: Dr Fergus Gracey, Senior Research Fellow1 
Collaborators: Dr Andrew Bateman, Reader and Director NIHR 
Research Design Service 2 & Dr Sara Simblett, Postdoctoral 
Research Associate3 
1Dept of Clinical and Applied Psychology, UEA,  2School of Health and Social Care, 
University of Essex, 3Institute of Psychiatry, Psychology and Neuroscience, London 
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Appendix H: Demographic Information  
1. What is your gender? – Male/Female/Other  
2. What is your age?  
3. Have you ever been admitted to hospital following a stroke? Yes/No 
4. If known, what type of stroke did you get hospitalised for? 
5. What was your age when first admitted to hospital following a stroke? 
6. Have you experienced multiple strokes? If you selected Yes, please write number of times: 
7. What is your marital status? – Single, never married/ Married or domestic partnership/ 
Widowed/ Divorced/ Separated 
8. What is the highest degree or level of school you have completed? 
9. At what age did you start school? 
10. At what age did you leave school? 
11. What is your current employment status? –  Employed full time/ Employed part time/ 
Unemployed and currently looking for work/ Unemployed and not currently looking for 
work/ Student/ Retired/ Homemaker/ Self-employed/ Unable to work 
12. Do you have any physical illness?  
13. Do you have any mental health conditions or alcohol/substance related disorders?  
14. Have you ever had any other neurological issues (including severe diabetes, epilepsy, 
traumatic brain injury, and subarachnoid haemorrhage)?  
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Appendix I: Dimensional Apathy Scale (DAS) – Self-Rated Version 
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Appendix J: Apathy Evaluation Scale – Self (AES-S) 
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Appendix K: Patient Health Questionnaire (PHQ-9) 
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Appendix L: Generalised Anxiety Disorder Questionnaire (GAD-7) 
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Appendix M: Consent Form 
CONSENT FORM 
Title of Project: Profiling Apathy after Stroke 
Name of Researcher: Pernille Myhre, Catherine Ford and Ratko Radakovic 
 
Please tick if you agree with the following statements:  
 I confirm that I have read the above information about this study,  
 I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, by closing the browser window. 
 I understand that the information collected about me will be used to support 
other research in the future and may be shared anonymously with other researchers. 
 I understand that my responses will not be identifiable once I have submitted the form, and 
that I will not be contacted based on the information I provide in this form.  
 By ticking this box, I agree to take part in the above study 
 
If you choose to take part in the study, you may be entered into a prize drawer where you 
could win one of five £25 Amazon Vouchers. If you would like to enter the price draw, please 
enter your email address: ___________________ 
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Appendix N: After Care Sheet 
Thank you for your participation in this research! 
The aim of the current study is to investigate the validity of a relatively new questionnaire, the 
Dimensional Apathy scale (Radakovic & Abrahams, 2014), to see if it can be used to assess 
apathy in stroke survivors.  
The results of this study will not include your name or any identifiable characteristics.  
If you have any questions related to the study, please contact the research team via the email 
address below. You might request a summary of the research findings of this project. If you 
would like a summary, please contact us via the email address below.   
(email address) 
If you need to talk to someone about any distress that might have resulted from participating 
in this study, please follow the guidelines in the After-Care Information sheet, such as talking 
to your GP.  
You can also call one of the following helplines: 
• The Stroke Association Helpline on 0303 3033 100 or email helpline@stroke.org.uk. This is  
• Silver Helpline on 0800 4 70 80 90. This is a free and confidential helpline “providing 
friendship, information and advice for older people, open every day for 24 hours 
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Appendix O: Thesis Budget Form 
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Appendix P: FMH REC approval of Thesis Proposal with Amendments 
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Appendix Q: FMH REC Ethical Approval Following Amendments 
   
POST-STROKE APATHY   174 
 
Appendix R: Email to FMH REC Regarding Ethical Issue 
Dear Chair of FMH Ethics Board, 
I am writing to you regarding FMH REC approval for thesis project ‘Profiling Apathy after Stroke’ (FMH REC 
ref 201819 – 026),  
This study is based on an online survey for stroke survivors and their carers. The survey uses measures of 
apathy (the Dimensional Apathy Scale, DAS and the Apathy Evaluation Scale, AES), mood (the PHQ9 
measure of depression and the GAD7 measure of anxiety) and executive functions (the Dysexecutive 
Syndrome scale, DEX) to provide an initial validation of the DAS in stroke, to aid detection and 
characterization of post-stroke apathy syndromes.  
The measure of executive functions (the DEX) is copyrighted, but we did not anticipate this being 
problematic, as we received permission from the company involved to include it in the online survey, 
provided survey access were controlled via individual access codes obtained by emailing the study email 
address. Initially this appeared a good way to incorporate the DEX questionnaire, which also allowed us to 
link data from stroke participants and family carers to provide a paired control group and informant 
ratings of motivation/apathy. 
Since starting the study however, we – Dr Catherine Ford (primary supervisor), Dr Ratko Radakovic 
(Secondary supervisor) and Pernille Myhre (trainee) – have become aware of difficulties with the use of 
access codes and have therefore halted recruitment, as there are currently issues with the following:  
1) The need for access codes raises difficulties preserving participant anonymity, as people may provide 
personal details in emails when requesting a code (e.g. name and stroke survivor status) and we have 
found that the online survey software records the code provided, so responses could potentially be linked 
back to emails. 
2) The PHQ9 measure of depression includes a question about suicidal thoughts and if participants are not 
fully anonymous, this raises questions about how to respond should a participant disclose suicidality.  
3) Recruitment has been very slow (N = 8) and it has been suggested this may reflect the requirement to 
email for an access code, as opposed to simply following a link online. 
We have halted study recruitment while seeking your advice and guidance on these issues. We have made 
some amendments to the study design to accommodate these issues, hoping this will ease recruitment as 
well as overcoming these ethical issues.  
As you can see in the tracked changes, we have removed elements of the study affecting anonymity, 
namely, the DEX measure and collection of paired data from stroke and stroke carer participants. We 
have included a control group of people that have not experienced a stroke as comparison. This would 
enable the link to the survey to be published online without need for access codes. Inclusion of the DEX is 
not critical to the primary aim of validating the Dimensional Apathy Scale and we could recruit an 
independent healthy controls group instead of a paired family carer group.  
Hoping in anticipation that this change will be accepted by the chair. 
Kind regards, 
Pernille Myhre 
Trainee Clinical Psychologist   
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Appendix S: FMH REC Ethical Approval of Amendment 
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Appendix T: Email to FMH REC Regarding Inclusion Criteria 
 
From: Pernille Myhre (MED - Postgraduate Researcher) <P.Myhre@uea.ac.uk>  
Sent: 15 November 2019 16:52 
To: FMH Ethics <fmh.ethics@uea.ac.uk> 
Cc: Catherine Ford (MED - Staff) <Catherine.Ford@uea.ac.uk>; Ratko Radakovic (HSC - Staff) 
<R.Radakovic@uea.ac.uk> 
Subject: Study: Profiling Apathy After Stroke 201819 - 026  
 
Dear FMH REC Committee, 
 Study: Profiling Apathy After Stroke 201819 - 026  
 We are delighted to inform you that we were able to recruit 62 stroke survivors and 80 controls to this 
study and have closed data collection.  
It has come to our attention, however, that a number of participants responded to our online survey 
despite meeting our exclusion criteria (“patients who have a major co-morbid medical, neurological or 
psychiatric history, including severe diabetes, epilepsy, traumatic brain injury, alcohol/substance related 
disorders, and subarachnoid haemorrhage). 
 I have discussed this with my primary and secondary research supervisors at UEA (Dr Catherine Ford and 
Dr Ratko Radakovic) and have consulted the literature on multimorbidity in the context of stroke. Many of 
the medical and psychiatric conditions that have been listed by participants are known risk factors for 
stroke or potential consequences of strokes, therefore it does not seem ethical to exclude their data. We 
would instead prefer to include all participants' data as far as possible, except when a major, stroke-
unrelated, neurological condition has been disclosed. 
This would entail the following change to our exclusion criteria: no major, medical, neurological or 
psychiatric co-morbidities unrelated to stroke (e.g. neither a potential risk factor or consequence of 
stroke).  
Please see amendment on page 37 of the protocol (attached). 
I would be grateful if you could advise on whether you would consider taking Chair’s action to approve 
this change to the protocol.  
  
Kind regards, 
Pernille Spillum Myhre 
 
Trainee Clinical Psychologist 
Department of Clinical Psychology 
Norwich Medical School 
University of East Anglia 
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Appendix U: FMH REC Ethical Approval of Change to Inclusion Criteria 
 
